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ABSTRACT 
Cytokinesis is the final chapter of cell division and its last page is abscission, the 
physical separation of two daughter cells. During cytokinesis of vertebrate cells, two 
future daughter cells are connected by an intercellular bridge within which the midbody 
(MB) is positioned. Since becoming the focus of intense investigations on cytokinesis 
completion, MB is now perceived as a complicated organelle where multiple pathways 
for abscission are targeted and coordinated. However, whether post-mitotic midbodies, 
the midbody derivatives (MBds), would be retained by either daughter cell post-
abscission remains unexplored. In addition, how cells manage the fate of inherited MBds 
is also unclear or only sketchily proposed. Finally, whether the inherited MBds in cells 
may play non-cytokinetic roles is also unaddressed.  
In the first chapter, I review the historical and current understanding of MBs, with 
emphasis on their roles in cytokinesis whereas potential non-cytokinetic roles are also 
covered. In the second chapter, the aforementioned three questions are sequentially 
addressed. First, the newly-formed MBd appears to be inherited by the daughter cell with 
the older centrosome. Second, MBds are not only inherited but also accumulated in 
cancer and pluripotent stem cells, but not in normal somatic (differentiated) cells. In 
normal somatic cells, MBds are within membrane-bound compartments for lysosome-
mediated degradation via autophagosome engulfment. This partially explains why MBd-
accumulation is rarely observed in these cells. In contrast to the previous model, 
colleagues and I showed that MBd-accumulation correlates well with the 
autophagosomal-lysosomal activity, but not with the proliferation rate. Finally, the 
experimental increase of MBd levels appears to enhance the anchorage-independent 
growth in cancer cells and the efficiency of reprogramming in fibroblasts. In the last 
chapter, I conclude our findings and discuss future directions in two aspects. 
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Chapter 1: Introduction to the Structure and Functions 
of Midbodies 
 
 
 
 
 
 
 
 
With minor alternations to standardize the format, this chapter was taken in its entirety 
from following manuscripts currently in preparation: 
Resurrecting remnants: the lives of post-mitotic midbodies 
Chun-Ting Chen and Stephen J. Doxsey 
Manuscript in preparation 
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ABSTRACT 
The midbody is positioned within the intercellular bridge that connects the two 
future daughter cells during the final stages of cytokinesis. It is one of the most 
complicated organelles assembled during cell division. This organelle is unique in being 
singular at a time when the cell is taking great care to divide its contents between the two 
daughters. The midbody has recently become the focus of intense investigation both in 
terms of its cytokinetic functions, and its unexpected life and functions after abscission. 
In this review, we provide historical and contemporary views of midbodies by connecting 
earlier work on morphological changes to recent novel findings.   
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INTRODUCTION 
Cell division requires segregation of the duplicated genome and partitioning of 
cellular contents. The latter is called cytokinesis, which in animal cells, begins with the 
ingression of plasma membrane powered by the actomyosin ring. It culminates in a 
dramatic but poorly understood event called abscission (see Glossary Box), where 
daughter cells are separated from each other (for reviews, Otegui et al., 2005; Eggert et 
al., 2006). Recent advances have uncovered several key features of abscission including 
membrane trafficking (Gromley et al., 2005; for review, Prekeris and Gould, 2008; 
McDonald and Martin-Serrano, 2009), microtubule (MT) reorganization (Connell et al., 
2009; Guizetti et al., 2011), spiral-shaped filament formation (Carlton and Martin-
Serrano, 2007; Guizetti et al., 2011; Elia et al., 2011), signaling from kinases and 
phosphoinositides (Steigemann et al., 2009; Bastos and Barr, 2010; Sagona et al., 2010), 
and the potential functions of midbody (MB; see Glossary Box) (Gromley et al., 2005; 
Fabbro et al., 2005; Zhao et al., 2006). Abscission failure can lead to syncytium 
formation and polyploidy, the potential factors in cancer predisposition and progression 
(Ganem et al., 2007). Several reviews have discussed the mechanistic underpinnings of 
abscission (see reviews cited above) and the link between cytokinesis failure and 
tumorigenesis (Ganem et al., 2007; King, 2008).  
Here, we focus on the MB, a structure embedded in the intercellular bridge (see 
Glossary Box) and essential for late cytokinesis. Earlier studies suggested that MBs 
simply deteriorated or were lost from the cell after division (Byers and Abramson, 1968; 
Mullins and Biesele, 1977). However, more recent studies show that the post-mitotic MB 
can persist for extended periods of time both in vivo and in vitro (Jantsch-Plunger et al., 
2000; Gromley et al., 2005; Goss and Toomre, 2008) and that retention of MBs depends 
on cell physiology and cell type (Pohl and Jentsch, 2009). These observations have 
resurrected the interest in MB form and function.  
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Early understandings of the midbody 
The midbody, or Zwischenkörper (“Zwischen” and “körper” mean “between” and 
“body”, respectively; also referred to as the Flemming body), was first described by 
Walther Flemming in the 1890s (Flemming, 1891; Paweletz, 2001). Using light 
microscopy (LM), he identified a chromophilic structure positioned between dividing 
daughter cells. He speculated that this MB was derived from the spindle midzone 
between segregating chromosomes (see Figure 1) and that it might be the animal 
counterpart of the phragmoplast (see Glossary Box), a MT-enriched structure involved in 
plant cytokinesis (Flemming, 1891; Hepler and Jackson, 1968; for reviews, Otegui et al., 
2005; Jurgens, 2005). A hundred years later, with the aid of advanced microscopy and 
methods to dissect protein functions, most of Flemming‟s prescient theories have been 
validated. 
The midbody is dynamic along the intercellular bridge  
In the 60s and 70s, mitosis researchers confirmed Flemming‟s hypothesis that MB 
biogenesis is initiated during late anaphase/early telophase when the cleavage furrow 
starts to ingress (Stage 1; see Figure 1a, top panel). They also confirmed that the overall 
structure of the early MB or “stem body” is strikingly similar to the developing 
phragmoplast (Hepler and Jackson, 1968), given that both midbody and phragmoplast are 
composed of anti-parallel MTs, amorphous electron-dense material, and vesicles (for 
reviews, Otegui et al., 2005; Baluska et al., 2006). 
With microcinematography, it was shown that the MB comes to lie within the 
intercellular bridge after furrow ingression has completed (Byers and Abramson, 1968; 
Mullins and Biesele, 1973). In vertebrate cells, it forms a disc-like structure of 1-2 m in 
diameter, which is approximately the same as the bridge‟s diameter (Stage 2; see Figure 
1a, middle panel). As the cell approaches abscission, the diameter of the intercellular 
bridge continues to narrow whereas MB size remains relatively constant. The plasma 
membrane of the bridge wraps tightly around the MB, creating a bulge in the bridge 
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(Stage 3; see Figure 1a, bottom panel) (Byers and Abramson, 1968; Mullins and Biesele, 
1973). In addition, the MB appears to slide between the two connected daughter cells; 
this movement has been attributed to the bending or waving cytoplasmic activities along 
the bridge (Mullins and Biesele, 1973). Later, the bridge on one side of the MB narrows 
to a thin thread of cytoplasm (Byers and Abramson, 1968; Mullins and Biesele, 1973). 
This early observation of asymmetric bridge narrowing is interesting in the context of 
later studies, which describe this and other asymmetric events that accompany abscission 
in more details (see below and Gromley et al., 2005; Giaetta et al., 2006; Goss and 
Toomre, 2008; Guizetti et al., 2011; Elia et al., 2011; Schiel et al., 2011). The multiple 
asymmetric events that occur during abscission could have consequences following 
completion of cell division (see below).  
The midbody is a complicated macromolecular assembly 
Electron microscopy provided additional insight into MB architecture and 
associated structures (Buck and Tisdale, 1962a and 1962b; Robbins and Gonatas, 1964; 
Paweletz, 1967; Brinkley and Cartwright, 1971; Mullins and Biesele, 1977; Moll and 
Paweletz, 1980). At early telophase, diverse membranous organelles such as 
mitochondria, cisternae of the endoplasmic reticulum (ER), Golgi complexes, and 
electron-lucent and -dense vesicles, localize among the MB/stem body MT bundles 
(Buck and Tisdale, 1962b; Robbins and Gonatas, 1964; Mullins and Biesele, 1977; Moll 
and Paweletz, 1980). Notable among these are double-membrane-bound electron-dense 
bodies that sometimes associate with multivesicular bodies (MVBs; see Glossary Box) 
(Robbins and Gonatas, 1964). It is of interest that these double-membrane-bound 
organelles are reminiscent of autophagosomes (see Glossary Box), recently implicated in 
fate-determination of post-mitotic MBs (see below and Pohl and Jentsch, 2009). After 
furrow ingression, the membranous organelles gradually decrease at MT sites and 
concomitantly appear at the junctions of the bridge and the cell bodies (see Figure 1; 
Robbins and Gonatas, 1964; Mullins and Biesele, 1977; Moll and Paweletz, 1980). 
Around the same time, MT bundles coalesce and compact, and the amorphous electron-
dense material reorganize into a continuous plaque-like structure between daughter cells, 
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the Flemming body (Buck and Tisdale, 1962b; Robbins and Gonatas, 1964; Paweletz, 
1967; Mullins and Biesele, 1977; Moll and Paweletz, 1980). It has been suggested that 
this structure provides a diffusion barrier between daughter cells, although the efficacy of 
this „barrier‟ is unclear (Sanger et al., 1985; Schmidt and Nichols, 2004; Steigemann et 
al., 2009), and channels have been identified in the MBs to connect the cytoplasm of the 
two future daughter cells (Mullins and Biesele, 1977). Discrepancies in the literature on 
this point may partly result from viewing cells at different times or under different 
conditions during cytokinesis.  
 In late telophase, the MB becomes a prominent structure that can be subdivided 
into a central MB core and flanking microtubules with associated structures (see Figure 
2a). The MB core is composed of the MB matrix containing mainly anti-parallel MT 
bundles and electron-dense material (Paweletz, 1967; McIntosh and Landis, 1971; 
Mullins and Biesele, 1977; for reviews, Barr and Gruneberg, 2007). The MB ridges are 
comprised primarily of electron-dense material and a specialized thickening under the 
plasma membrane with few MTs (see Figure 2a; Mullins and Biesele, 1977), and 
correspond to the MB rings (MRs) revealed more recently by immunofluorescence (IF; 
see Figure 2a). As cytokinesis progresses, MT bundles within the bridge are reduced 
presumably by severing and depolymerization (McIntosh and Landis, 1971; Brinkley and 
Cartwright, 1971; Mullins and Biesele, 1977), and vesicles cluster increasingly at or close 
to the MB as well as along MTs (Robbins and Gonatas, 1964; Paweletz, 1967; Mullins 
and Biesele, 1977). After vesicles traffic to the MB, where they presumably dock and 
fuse, and the final reduction of MT bundles, abscission follows shortly thereafter 
generating MB derivatives (MBds).  
Discrepant views of the inheritance of midbody derivatives 
The earlier EM studies suggested that post-abscission or post-separation MB 
„remnants‟ were transient structures that were ultimately discarded (Buck and Tisdale, 
1962a; McIntosh and Landis, 1971; Mullins and Biesele, 1977). These MB remnants or 
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derivatives (MBds) appeared outside cells with recognizable MB matrix, ridges, and 
plasma membrane (Mullins and Biesele, 1977). However, without the ability to track 
cells over time, the interpretation of MBd images obtained by EM is limited. It is possible 
that aged MBd became unrecognizable by EM due to the changes of MBd architecture 
over time. In fact, by immuno-electron microscopy (iEM), Dubreuil et al (2007) recently 
showed that „aged MBds‟ evolved to be morphologically distinct from mitotic MBs, as 
they resembled large homogeneously-sized electron-dense vesicles (~600 nm in 
diameter). It is also known that MBds are modified through disorganization and loss of 
MTs (Mullins and Biesele, 1977) as well as through changes of the molecular 
components that remains in MBds (Baron and Doxsey, unpublished).  
Discrepancies in the results described above reflect the need for a multi-faceted 
imaging strategy to investigate MBd inheritance, retention, and fate. This includes the use 
of time-lapse microscopy, fluorescent-protein labeling, IF, and correlative EM. With the 
aid of these techniques, the Doxsey laboratory and others have shown that the MBd 
remains associated with one of the two daughter cells after abscission (Gromley et al., 
2005; Dubreuil et al., 2007; Goss and Toomre, 2008). Closer inspection reveals a thin 
connection between the MBd and a daughter cell reminiscent of the thin stalk described in 
the earlier studies using microcinematography and EM (Byers and Abramson, 1968; 
Mullins and Biesele, 1973 and 1977). In the end, this „tether‟ may be retracted and the 
MBd comes to reside inside one of the two daughter cells after abscission (Gromley et al., 
2005; Pohl and Jentsch, 2009) or, alternatively, may be severed later to completely 
disconnect MBds from the cell (Guizetti et al., 2011; Elia et al., 2011). However, whether 
the „disconnected‟ MBds would be further phagocytosed or simply dissociated from cells, 
and disintegrated extracellularly (Buck and Tisdale, 1962a; McIntosh and Landis, 1971; 
Mullins and Biesele, 1977) is still unclear.  
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Recent insights into the midbody: roles in abscission 
The proteome of taxol-stablized MBs revealed at least 160 protein components and, 
when considering the expanded estimates, as many as 500 (Skop et al., 2004). However, 
the composition of MBs could be more complicated given the fact that MB proteins may 
associate transiently with the MB and change positions within the MB during cytokinesis 
progression. For example, Aurora B kinase localizes along the bridge post-furrowing but 
is present at the MR during abscission, potentially reflecting its role(s) in abscission 
timing (Murata-Hori et al., 2002; Steigemann et al., 2009). Such changes in the spatial 
distribution of MB proteins and molecular composition of MBs/MBds may reflect the 
observed architectural changes of MBs (see above).    
In last few years, renewed interest in the MB has led to the discovery of novel 
molecules and pathways that contribute to abscission. The known functions of these 
pathways in other cellular processes have led to the generation of testable hypotheses for 
the mechanisms of abscission, MBd inheritance and MBd retention. These pathways 
include vesicle trafficking, membrane scission, MT-severing, ubiquitination, and 
autophagy machinery. In the following sections, we focus on the potential impact of these 
pathways on MB and MBd biology. 
Membrane trafficking pathways are recruited to the midbody 
Multiple membrane trafficking and sorting pathways were recently found crucial 
for abscission (for reviews, Barr and Gruneberg, 2007; Prekeris and Gould, 2008; 
Montagnac et al., 2008; McDonald and Martin-Serrano, 2009), but their precise roles and 
coordination during late cytokinesis is still poorly understood. This is not a complete 
surprise since early EM studies identified a variety of vesicle types at MBs during early 
cytokinesis and prior to abscission. The Doxsey laboratory and others have shown that 
multiple components of the exocyst (see Glossary Box) traffic to the MB during 
cytokinesis (Gromley et al., 2005; Fielding et al., 2005; Cascone et al., 2008). This 
recruitment at least relies on centriolin, a mother centriole and MB protein (Gromley et 
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al., 2003), and also on small GTPase RalA and RalB, since the depletion of these 
molecules blocks the proper MB localization of the exocyst (e.g., Sec5, Sec6, Sec8 and 
Exo84) (Gromley et al., 2005; Cascone et al., 2008). Moreover, depletion of exocyst 
components or expression of the binding-defective mutant phenocopies the late 
cytokinesis defects and binucleated cell formation observed in centriolin-silenced cells 
(Gromley et al., 2005; Fielding et al., 2005; Cascone et al., 2008). In addition to exocyst, 
the MB localization of SNAREs (see Glossary Box), such as endobrevin/VAMP8 and 
syntaxin-2, and their associated protein, snapin, is also shown to depend on at least two 
MB proteins, centriolin and CEP55 (Low et al., 2003; Gromley et al., 2005; Zhao et al., 
2006). Collectively, MB functions as a central anchoring scaffold, allowing Golgi-
derived vesicles to properly target at the MB ring and potentially facilitating en mass 
vesicle fusion for abscission.  
In the study of Gromley et al. (2005), vesicles appear to be targeted primarily at one 
side of the MB prior to abscission. This observation is consistent with the reported 
asymmetric accumulation of Golgi-derived vesicles at the two sides of MB during late 
cytokinesis, even though the initial accumulation is symmetrical around the MB (Goss 
and Toomre, 2008). With better temporal resolution, the recruited Golgi-derived vesicles 
appear to dock at the MB but persist individually without homotypic (vesicle-vesicle) 
fusion (Goss and Toomre, 2008), further supporting the model of en mass fusion for 
abscission. Conceptually similar, Gaietta and colleagues (2006) showed that small Golgi 
complexes formed on each side of the intercellular bridge at the junction with the cell 
body, in addition to the dominant Golgi complexes positioned behind the nucleus on the 
far side of each nascent daughter cell. Late in cytokinesis, one of the smaller Golgi 
complexes was retracted to the nucleus earlier than the other. This left the other in a 
position to deliver Golgi-derived vesicles to one side of the MB presumably to mediate 
asymmetric abscission of the bridge through both heterotypic (vesicle-plasma membrane) 
and homotypic fusion at this site (Gaietta et al., 2006). In any case, the consequence of 
these events would be the inheritance of MBd by the nascent daughter cell opposite the 
fusion site (Gromley et al., 2005; Goss and Toomre, 2008).  
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The endosomal pathway also contributes to abscission (for reviews, Prekeris and 
Gould, 2008; Montagnac et al., 2008). The endosome-associated Rab11-interacting 
proteins, FIP3 and FIP4, move symmetrically into the bridge and up to both sides of the 
MB (Wilson et al., 2005). FIP3/4 has been shown to interact with at least one exocyst 
component, Exo70, and one MB protein, MgcRacGAP/Cyk4, and these interactions are 
essential for completing cytokinesis (Fielding et al., 2005; Simon et al., 2008). Goss and 
Toomre (2008) also showed that endosomal vesicles trafficked symmetrically into the 
bridge or docked around the MB; however, this pool of vesicles remains distinctive from 
Golgi-derived vesicles, implying their different roles throughout cytokinesis. Indeed, 
Schiel et al., (2011) showed that the fusion of FIP3+ endosomes generated the waving 
activity of intercellular bridge to further extend and/or narrow down the bridge during 
late cytokinesis, as observed in earlier studies (Byers and Abramson, 1968; Mullins and 
Biesele, 1973). However, the waving activity on each side of the MB was stated as 
sequential or asymmetric, suggesting that the fusion of FIP3+ endosomes that were 
symmetrically recruited might be differentially regulated. One potential regulator is the 
localized MT severing and depolymerization that occur predominantly in an asymmetric 
manner and are permissive factors for fusion, as observed in Schiel et al., (2011).  
Despite different types of membrane trafficking events, the MBd is still inherited 
asymmetrically by one daughter cell and is seldom released from cells as might be 
expected for symmetric vesicle recruitment on both sides of the MB (Wilson et al., 2005; 
Gromley et al., 2005; Goss and Toomre, 2008). One scenario is that even though vesicles 
are symmetrically recruited, fusion events are still „asynchronous‟ or even sequential 
presumably due to the limiting factor(s) on one side of the MB but not on the other side. 
The secretory vesicles that are present symmetrically during early cytokinesis and 
asymmetrically during late cytokinesis (Goss and Toomre, 2008) may reflect the 
differential fusion or accumulation on each side of the midbody, as also proposed for the 
fusion of FIP3+ endosomes (Schiel et al., 2011). In Box 1, detailed models explain how 
different types of membrane trafficking events may potentially lead to the asymmetric 
MBd inheritance.  
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ESCRT complexes at the MB: Role in membrane scission? 
An unexpected recent discovery was that the ESCRT pathway (see Glossary Box) is 
required for cytokinesis (Carlton and Martin-Serrano, 2007). This pathway has been 
studied for decades in the context of viral budding and MVB formation (for reviews, 
Railborg and Stenmark, 2009; McDonald and Martin-Serrano, 2009). Thus, it came as a 
surprise that ESCRT is also an evolutionarily-conserved machinery for cytokinesis 
completion in archaea, plants, and vertebrates cells (Spitzer et al., 2006; Carlton and 
Martin-Serrano, 2007; Samson et al., 2008). Appealing to those in the field was the 
topological similarity between viral budding and cytokinesis in animal cells, namely the 
thin neck of a budding vesicle and the thin intercellular bridge during abscission 
(Railborg and Stenmark, 2009; McDonald and Martin and Serrano, 2009). Lee et al. 
(2008) showed that Alix, an ESCRT-associated protein, and Tsg101, a component of 
ESCRT-I, both bound to CEP55, a MB protein crucial for cytokinesis completion 
(Fabbro et al., 2005). Depleting either Alix or Tsg101 or disturbing their binding to 
CEP55 appeared to inhibit abscission and induce binucleated cell formation, suggesting 
the close interaction between ESCRT and MBs (Morita et al., 2007; Carlton and Martin-
Serrano, 2009). Recently, it was shown that ESCRT-III components formed spiral-shaped 
filaments associated with membrane, driving membrane deformation and scission, and 
that Vps4, a AAA+ ATPase required for ESCRT disassembly and recycling, ensured 
scission to occur efficiently and repeatedly (Hanson et al., 2008; Saksena et al., 2009; 
Wollert et al., 2009). Therefore, an analogous mechanism can operate during abscission, 
whereby ESCRT interacts with AAA+ ATPases to sever MTs (e.g. spastin; Yang et al., 
2008) and forms spiral-shaped filaments close to the MB for bridge membrane scission 
(Guizetti et al., 2011; Elia et al., 2011). Taken together, these findings are in agreement 
with earlier LM and EM observations of membrane deformation during late cytokinesis 
(Byers and Abramson, 1968; Mullins and Biesele, 1973 and 1977), membrane budding 
(as in viral budding) at the MB ridges upon abscission (Buck and Tisdale, 1962a; Mullins 
and Biesele, 1977), and microtubule reduction in late telophase (Buck and Tidsale, 1962b; 
Brinkley and Cartwright, 1971; Mullins and Biesele, 1977). 
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However, several issues with the ESCRT model for abscission still remain 
unresolved. ESCRT-tethered vesicles are believed to have diameters ranging from 50 to 
100 nm (McDonald and Martin-Serrano, 2009; Railborg and Stenmark, 2009), whereas 
the diameter of the intercellular bridge is 5 to 20 fold larger, depending on the stage of 
abscission (Mullins and Biesele, 1977; Gromley et al., 2005; Guizetti et al., 2011). 
Recently, Guizetti et al. (2011) reported the appearance of 17-nm spiral-shaped filament 
at the abscission site where the bridge diameters range from 200 to 500 nm and that 
appearance is dependent on CHMP2, a core component of ESCRT-III. However, whether 
this filament is comprised of ESCRT-III is not validated yet, and how the putative 
ESCRT filament functions as a molecular scissor in this paradigm is also unclear. One 
idea is that other types of vesicles (e.g. endosomal and/or Golgi-derived vesicles; see 
above) recruited to the MB during cytokinesis contribute to narrowing the bridge to a 
caliber sufficient for ESCRT-mediated abscission, but not to fusion-mediated abscission 
per se. Indeed, some earlier EM work, as well as recent studies, showed that the bridge 
lengthens and becomes significantly thinner before abscission, presumably due to 
massive fusion events (Byers and Abramson, 1968; Mullins and Biesele, 1973; Gromley 
et al., 2005; Zhao et al., 2006; Schiel et al., 2011). An alternative model is that the 
ESCRT itself, through a membrane budding mechanism, extrudes membrane and 
cytoplasm into the extracellular environment to narrow the bridge caliber, as observed 
previously (Buck and Tisdale, 1962a; Mullins and Biesele, 1977; Dubreuil et al., 2007). 
A third model implicates the ESCRT in more global activity along the length of the 
bridge, possibly acting on larger vesicles to promote abscission (J Hurley, personal 
communication). Although detailed mechanisms of membrane scission at the intercellular 
bridge remain to be determined, it is clear that the ESCRT pathway is crucial for 
abscission.  
Role of de/ubiquitination in modifying the MB upon abscission 
In line with the ESCRT model of abscission, Mukai et al (2008) showed that two 
ESCRT-modulating deubiquitinating enzymes (DUBs), UBPY/USP8 and AMSH, were 
recruited to the MB during cytokinesis. Depletion of either DUB led to cytokinesis failure. 
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AMSH depletion induced binucleated cells and cells with long bridges, and UBPY 
depletion induced binucleated cells. This phenotypic difference may reflect different 
specificities of the two DUBs toward different MB protein substrates and ubiquitin 
conjugates (Mizuno et al., 2006; Row et al., 2007; Mukai et al., 2008). As proposed, 
from anaphase to cytokinesis, the spatial distribution of UBPY and AMSH is different, 
suggesting selective interactions with different ESCRT and non-ESCRT molecules, 
which could be crucial for ordered abscission. Another study supports a role for 
ubiquitin-related modifications in abscission by showing that BRUCE, a giant protein 
possessing E2/E3 ubiquitin ligase activity (Hauser et al., 1998), moved to the MB, 
interacted with MB components (e.g. Mklp1), and blocked abscission when depleted 
(Pohl and Jentsch, 2008). Importantly, the MB fraction of both BRUCE and Mklp1 was 
heavily mono- or oligo-ubiquitinated upon abscission, and both proteins appeared to be 
targeted by UBPY (Pohl and Jentsch, 2008). Taken together, ubiquitinating enzyme(s) 
and ESCRT-interacting DUBs modulate the ubiquitination status of MB proteins, which 
may play a role in MBd fate determination (see below). 
Macroautophagy-mediated degradation of the midbody derivative 
Another intriguing discovery was the degradation of MBds by macroautophagy 
(hereafter referred to as autophagy; Pohl and Jentsch, 2009; also see Chapter 2). 
Autophagy was originally identified as a mechanism to recycle amino acids when cells 
faced nutrient deprivation, but is now known to be also involved in cell survival/death, 
clearance of damaged protein/organelles, tumorigenesis, and embryonic development 
(Liang et el., 1999; Klinosky et al., 2007; Tsukamoto et al., 2008). Autophagosomes 
engulfing sequestered molecules or organelles subsequently fuse with lysosomes directly 
or indirectly to degrade their contents (Berg et al., 1998; Klinosky et al., 2007). Pohl and 
Jentsch (2009) showed that ubiquitinated MBds recruited p62, an autophagic receptor and 
ubiquitin-binding protein, which in turn attracted the autophagosome-associated protein 
LC3 to form autophagosomes. It was thus proposed that MBd degradation is tightly 
coupled with abscission and that rapidly-dividing cells accumulate MBds due to 
insufficient time between divisions for MBd degradation. More recently, the Doxsey 
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laboratory demonstrated the involvement of another autophagic receptor, NBR1, in MBd 
degradation via its specific binding to CEP55, and suggested that it may function 
independently from p62 (Chapter 2). Collectively, both groups showed that autophagy is 
the main pathway for MBd degradation by modulating autophagic or lysosomal activities 
with different pharmaceutical reagents or with RNAi technology.   
With these findings, the earlier perception of post-mitotic MBs as transient 
structures jettisoned from cells as remnants that degenerate extracellularly (Robbins and 
Gonatas, 1964; Mullins and Biesele, 1977), is now giving way to the idea that these MBds 
may be more permanent entities that recruit specific molecules to manage their fates 
(Pohl and Jentsch, 2009; Chapter 2), or even contribute to secondary cellular functions 
during interphase (Bellairs and Bancroft, 1975; Dubreuil et al., 2007; Wilcock et al., 
2007). In short, MBds can undergo intracellular retention, regulated degradation, or 
extracellular deposition/delivery (Mullins and Biesele, 1977; Pohl and Jentsch, 2009; 
Chapter 2), though their fate determination has not been investigated in detail.  
MB
d
 degradation is cell type-dependent 
In the model of Pohl and Jentsch (2009), MBd accumulation would be inversely 
correlated with the population doubling-time. However, work from the Doxsey laboratory 
led to a different interpretation (Chapter 2). It was suggested that the mechanism for MBd 
fate determination is more complex and appears to be cell type-dependent (see Text Box 
2). The underlying reason for different models proposed by the two groups was likely the 
assay used for MBd retention and accumulation. The Jentsch laboratory used a marker 
present on both mitotic MBs and post-abscission MBds (Gromley et al., 2005; 
Steigemann et al., 2009; Pohl and Jentsch, 2009). Therefore, in rapidly-dividing cells, the 
increase in marker-positive MBs may not accurately reflect an increase in MBds. This 
issue was overcome by the use of a second marker (e.g. -tubulin and Aurora B) to 
distinguish MBds from MBs (Chapter 2).  
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Expansion of the analysis to different cell types showed that MBds in vivo and in 
vitro accumulated in stem cells but in neither primary cultured cells nor immortalized 
somatic (differentiated) cell lines, regardless of the pace of cell cycle progression 
(Chapter 2). In general, primary and normal cells possess high autophagic activity, 
suggesting that MBds are efficiently degraded in these cells, whereas stem cells (e.g. 
hESCs) and cancer lines that accumulated MBds showed low autophagic activity (Liang 
et al., 1999; Chapter 2). When hESCs were induced to differentiate and then reprogram, 
MBd loss and accumulation accompanied accordingly, nicely correlating inversely with 
autophagic activity (Chapter 2). Similarly, the few cancer cell lines that do not 
accumulate MBds exhibit elevated autophagy levels, again indicating that MBd 
degradation is more dependent on autophagic activity, rather than the temporal-coupling 
with abscission. An important remaining question is whether cancer cells that accumulate 
MBds represent a special group of cells within the heterogeneous population, possibly 
cancer stem cells (CSCs)/cancer initiating cells.      
Several models could explain why MBd accumulation occurs in certain cell types 
and correlates inversely with autophagic activity: (1) autophagic activity could be 
increased during differentiation or participate in cell fate determination leading to low 
MBd levels; (2) certain molecules required for targeting MBds for degradation might not 
be expressed or expressed poorly in stem cells, or (3) accumulated MBds could actively 
participate in stem cell maintenance and renewal. Model 1 is supported by the 
demonstrated roles of autophagy in early embryo development (Tsukamoto et al., 2008). 
However, the precise mechanism involved in autophagy control of cell fate 
determination has not been identified. Model 2 is plausible, but so far the known 
molecules (e.g. p62 and NBR1) that recruit autophagic machinery to MBs are also 
detectable in pluripotent cells (Kuo and Doxsey, unpublished). Thus, we favor model 3, 
and would like to discuss the potential functions and fates of MBds in stem cells (see 
below).  
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Possible non-cytokinetic roles of MB
d
s in stem cells 
Despite the difficulties associated with dissecting the causal relationship between 
autophagy, MBd accumulation, and stem cell functions/properties, recent results from the 
Doxsey laboratory suggest that MBd-containing cells possess properties distinct from 
cells lacking MBds. For example, more anchorage-independent colonies formed from the 
MBd-high subpopulation of cancer cells, the isolation of which was based on the 
fluorescent signal of the tagged MB protein. Consistent with the distinctive properties, a 
7-fold increase of MBd+ cells was found in the side-population (SP), the putative CSCs 
(Engelmann et al., 2008), compared with the non-SP cells. Moreover, when MBd 
degradation was specifically diminished by NBR1 depletion without affecting the bulk 
autophagic activity, the MBd-enriched cancer lines gained proportional increase of soft-
agar colony formation (Chapter 2). Stable increase of MBd+ fibroblasts by NBR1-
silencing also led to more efficient reprogramming processes (Chapter 2). The above 
results suggest that MBd accumulation and degradation play more active roles in the 
functions and properties of stem cells and their differentiation although other unknown 
NBR1 targets might be involved in this theme as well.  
Other observations are consistent with the proposed non-cytokinetic roles of MBs in 
stem cells. For example, MBds in the developing central nervous system contain 
CD133/prominin-1, a stem cell marker, and are not increasingly released into the 
ventricle until neurogenesis (Marzesco et al., 2005; Dubreuil et al., 2007). It has been 
proposed that the released MBds function as intercellular messengers between 
neuroepithelial (NE) cells (see Glossary Box) to balance proliferative and differentiating 
divisions. An alternative interpretation of why MBds are shed from NE cells is discussed 
in Text Box 3. MBds in neural cells are also suggested to provide orientation cues, as they 
appear to generate apical processes or determine where the apical processes forms shortly 
after division (Wilcock et al., 2007). Interestingly, Kieserman et al (2008) reported that 
the MB protein PRC1 was expressed differentially during Xenopus embryogenesis and 
recruited to MBs at different times in specific tissues, the tail-bud epithelium and 
neuroepithelium. This observation raises the possibility that MBs and MBds may be 
specialized in certain types of tissues in vivo, and this specification could potentially lead 
25 
 
to different fates or functions of MBds. These recent observations provide provocative 
insights into post-mitotic midbodies beyond their previously ascribed fates as remnants.  
New viewpoints in MB biology 
For almost a century, the MB has been perceived simply as a link between two 
dividing daughter cells (Flemming, 1891; Paweletz, 2001). Not long ago, its role as an 
organizing site for abscission was proposed (Gromley et al., 2005; Fabbro et al., 2005; 
Zhao et al., 2006; Carlton and Martin-Serrano, 2007; Lee et al., 2008; Goss and Toomre, 
2008). The similarities in molecular pathways employed for abscission suggest that this 
process is highly conserved (Otegui et al., 2005; Baluska et al., 2006). Moreover, based 
on the diversity of proteins associated with MBs identified in numerous studies and the 
„MB parts list‟ obtained from mass spectrometry (Skop et al., 2004), additional functions 
of MBs and MBds will surely be uncovered for years to come. 
Prominent among the shared features of abscission are the critical roles of membrane 
trafficking and cytoskeleton remodeling around the MB (see Figure 1). As discussed 
above, data from many studies and implications from the MB proteome indicate that 
multiple pathways converge close to or at the MB during abscission (Thompson et al., 
2002; Low et al., 2003; Skop et al., 2004; Gromley et al., 2005; Wilson et al., 2005; 
Carlton and Martin-Serrano, 2007; Goss and Toomre, 2008; Connell et al., 2009; Guizetti 
et al., 2011; Elia et al., 2011). Although how these pathways mediate abscission is still on 
debate, one must consider cooperative functioning of multiple pathways either 
consecutively or concordantly, as essential for this process. For example, vesicle fusion 
along the bridge to narrow the bridge caliber might be a prerequisite for the mechanism 
of ESCRT-mediated scission. Nonconventional pathways should also be considered; for 
example, integration of otherwise distinct pathways, as suggested in recent work showing 
convergence of the secretory and endocytic pathways to regulate secretory vesicle cargo 
release (Jaiswal et al., 2009). Similarly, in addition to membrane scission, ESCRT may 
coordinate MT disassembly in the bridge by timed interaction with MT-severing proteins 
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(Yang et al., 2008). This coordination could be a critical factor during abscission. 
However, the complete MT loss prior to abscission may not be required given that a 
considerable number of MT bundles is still retained and transferred with MBds following 
abscission (Gromley et al., 2005; Guizetti et al., 2011).  
 
The inheritance and retention of the MBd by one daughter cell after cell division is 
quite a remarkable event. Unlike other cellular organelles and structures, which are either 
duplicated (e.g. chromosomes, centrosomes) or present in multiple copies (e.g. 
peroxisomes, mitochondria, Golgi apparatus) in a mitotic cell, the MBd is singular. In this 
regard, the two genetically identical daughter cells are not created equal. One inherits a 
large organelle comprised of hundreds of proteins; the other receives no MBd. Although 
highly suggestive evidence for the functional significance of MBds is now revealed (see 
above), more remaining questions await. One of which would be to dissect whether and 
how the retained MBds affect the cellular properties in the context of cell lineages or 
tissue types. In any case, it is clear that the current perception of MBds has risen from 
remnants jettisoned from cells to post-mitotic organelles serving other unexpected 
functions.  
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GLOSSARY BOX  
Abscission: The final stage of cytokinesis that culminates in severing the intercellular 
bridge to generate two physically separate daughter cells. This process requires several 
membrane trafficking and remodeling pathways as well as machinery for microtubule 
severing. 
Midbody (MB): A prominent organelle located within the intercellular bridge. It is 
comprised of a central proteinaceous disc or ring-like core flanked by microtubules that 
overlap within the ring region as anti-parallel bundles. This core is also referred to as 
Flemming body or midbody ring (MR). The MB undergoes many morphological and 
molecular changes prior to abscission, and is essential for the completion of cell division.  
Intercellular bridge:  The cytoplasmic connection between a dividing cell in late 
cytokinesis that contains the midbody and is the ultimate site of cell separation.  
Phragmoplast: A spindle-derived structure formed during plant cytokinesis primarily by 
Golgi-derived vesicle trafficking. It is also comprised of microtubules, actin and other 
membranous components.  
Multivesicular body (MVB): A specialized membranous compartment in the endosomal 
pathway characterized by internalized vesicles within its lumen. After fusing with 
lysosomes, the molecular contents within MVBs can be degraded. 
Autophagosome: An intracellular double-membrane vacuole/vesicle formed de novo that 
engulfs molecules or organelles from the cytoplasm and degrades them by fusing with 
lysosomes. Autophagosome formation is known to require the autophagy-related gene 
(Atg) 6, or Beclin-1, and two ubiqutin-like conjugation systems (e.g. LC3/Atg8).  
Midbody derivative (MB
d
): The post-abscission midbody, previously also referred to as 
the post-separation midbody, midbody remnant, or division remnant.  
Exocyst: A protein complex required for the tethering and targeting of post-Golgi 
vesicles to the plasma membrane for secretion and abscission. 
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SNAREs: An acronym of Soluble NSF Attachment Protein REceptors. This is a large 
protein superfamily whose major function is to facilitate fusion between vesicles and the 
membrane of target compartments. SNAREs can thus further be divided to vesicle 
SNAREs (v-SNAREs) such as endobrevin/VAMP8, and target SNAREs (t-SNAREs) 
such as syntaxin-2. 
Endosomal sorting complex required for transport (ESCRT): A protein complex 
containing four subcomplexes (ESCRT-0, -I, -II and -III) that sorts and transports target 
molecules to endosomes. It is required for viral budding and has recently been shown to 
play a role in abscission. 
Neuroepithelial (NE) cells: The primary neural progenitors in the vertebrate central 
nervous system. 
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TEXT BOXES 
Text Box 1. Proposed mechanisms for asymmetric inheritance of MB
d
s 
Symmetric vesicle trafficking stochastic abscission MB release. One model 
for asymmetric inheritance of MBds is that symmetric vesicle trafficking and membrane 
scission machinery lead to bridge cutting on either side of the MB, but not both sides 
simultaneously. Ultimately, both sides of the MB would be severed, as recently suggested 
(Guizetti et al., 2011; Elia et al., 2011). This appears to be the case for cells in which 
MBds are released extracellularly. For example, MBds of neural progenitors are released 
into the ventricle after divisions in the cerebral cortex (Marzesco et al., 2005; Dubreuil et 
al., 2007). It is also possible that MBds that remain connected to one daughter cell by a 
thin stalk for extended time (Byers and Abramson, 1968; Bellairs and Bancroft, 1975; 
Mullins and Biesele, 1977; Gromley et al., 2005; Dubreuil et al., 2007) can ultimately be 
severed if membrane scission- or fusion-mediated abscission is inefficient and takes 
longer on one side of the MB than the other. Two early studies described “bending” or 
“waving” activity propagating away from both sides of the MB as the cell approaches 
abscission (Byers and Abramson, 1968; Mullins and Biesele, 1973). Abscission occurs on 
the side of the MB that continues undergoing waving movements, after the waving ceases 
on the other side (Byers and Abramson, 1968). These observations are consistent with the 
idea that severing capability (presumably the activity of membrane scission or vesicle 
fusion) on the two sides may be different, despite symmetric vesicle trafficking. 
Asymmetric vesicle trafficking asymmetric abscission MB retention by one 
daughter cell. A second model is that other types of vesicles are recruited asymmetrically 
to the MB for abscission. The Doxsey laboratory has compared the timing of recycling 
endosomal vesicle-transport  (GFP-tagged FIP3 or Rab11) and secretory vesicle-transport 
(luminal-RFP) to MBs. Luminal+ vesicles trafficked to the MB significantly later than 
FIP3 and Rab11 vesicles, suggesting that different vesicle types may function at different 
times and traffic in different manners during abscission (Rosa and Doxsey, unpublished). 
It also suggests that experiments should be normalized to a given endpoint, say, 
abscission, to reliably compare contributions of different classes of vesicles and results 
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from different investigators. Along these lines, most studies on vesicle transport during 
cytokinesis showed vesicle movement, accumulation and/or fusion at the MB ten or more 
minutes prior to abscission (Gromley et al., 2005; Wilson et al., 2005; Gaietta et al., 2006; 
Goss and Toomre, 2008). The delay between membrane trafficking/fusion and abscission 
described thus far implicates the existence of other unidentified species of vesicles or 
other critical events to eventually complete abscission as suggested in a recent report 
(Guizetti et al., 2011; Elia et al., 2011).  
Asymmetric signaling asymmetric abscission MB retention by one daughter 
cell. The third model predicts that membrane fusion is a regulated process that occurs 
only on one side of the MB despite vesicle delivery to both sides. The regulation of 
membrane fusion/scission and abscission could be through asymmetric removal of 
limiting factors (e.g. MT bundles; Schiel et al., 2011), the recruitment of fusion activators 
(e.g. kinase) or stimulation of a previously positioned activator by other means (e.g. Ca++ 
release) as in regulated secretion, for example, insulin granule secretion (for review, 
Pickett and Edwardson, 2006; Eliasson et al., 2008).  
Combinations of these models are also possible. For example, triggers of membrane 
fusion/scission for abscission could be recruited asymmetrically to the MB or 
sequentially to either side of the MB, as proposed in the second possibility, or activated 
asymmetrically, as proposed in the third possibility.      
Text Box 2: Proposed models for fate determination of MB
d
s 
Together with observations over the past century and some judicious speculation, 
we propose a working model for fate determination of MBds. Primary cultured cells and 
cell lines derived from differentiated somatic cells usually possess high autophagic 
activity. MBds in these cells would be ubiquitin-tagged and subjected to autophagy-
mediated lysosomal degradation (Pohl and Jentsch, 2009; Chapter 2). In cell types with 
low autophagic activity, such as pluripotent stem cells and a subpopulation of cancer cells, 
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MBds would accumulate. MBds in stem cells might harbor factors essential for stem cell 
maintenance or homeostasis during development (e.g. Prominin-1+ MBds and also see 
Text Box 3). Alternatively, MBds could sequester factors that drive differentiation, thus 
allowing stem cell activities to predominate. Along the same lines, differentiating cells 
would up-regulate autophagic activity, potentially accelerating the removal of original 
cellular constituents, including accumulated MBds, to re-establish different cellular 
functions and fates, as recently shown in c. elegans (Zhang et al., 2009). However, it is 
unclear whether MBd degradation drives differentiation or is a consequence of the 
differentiation processes.  
In this model, MBd-accumulation could be a double-edged sword in terms of 
cellular homeostasis. MBds might be necessary and beneficial to the properties of normal 
stem cells but detrimental in that they may contribute to cancer in the context of the 
cancer stem cell theory of tumorigenesis. Most cancer cells examined have lower 
autophagy levels than normal cells (Liang et al., 1999; Chapter 2), which would allow 
MBd-accumulation. While this state may positively promote normal stem cell viability 
and maintenance, it also has the potential to produce more cancer stem cells. In this 
scenario, stem cells with high MBd levels would occasionally acquire mutations and give 
rise to (stem) cells with tumorigenic properties, becoming CSCs or cancer initiating cells. 
In a slightly different scenario, normal somatic cells with rare MBds would occasionally 
lose the ability to efficiently degrade them. Such MBd retention and further accumulation 
could trigger the development of stem cell properties in undesired cells, through 
deregulation of cellular physiology toward cancer predisposition. This is consistent with 
the observation that only a fraction of cancer cells have multiple MBds. Future studies 
would definitely be required to test this model.  
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Text Box 3: The potential functions of MB
d
s: a case study 
Recently, Huttner‟s laboratory showed that MBds in the developing central nervous 
system (CNS) seem to have different fates and functions during neurogenesis (Marzesco 
et al., 2005; Dubreuil et al., 2007). It has long been known that proliferative divisions of 
neuroepithelial (NE) cells are symmetric, whereas neurogenic divisions are primarily, but 
not exclusively, asymmetric (Huttner and Kosodo, 2005). In other words, when a NE cell 
divides symmetrically, it produces either two NE daughter cells or two neurogenic 
daughter cells committed to differentiate. Symmetric divisions occur in parallel with the 
tissue plane whereas asymmetric divisions occur off parallel, the extreme being 
perpendicular to the tissue plane (Huttner and Kosodo, 2005; Dubreuil et al., 2007). The 
tilted division plane not only determines cell fate but also impacts where the MBd 
localizes after cytokinesis (Dubreuil et al., 2007).  
   
At the onset of neurogenesis (E9.5), NE cells are actively cycling via symmetric 
proliferative divisions and thus producing MBds that harbor CD133/Prominin-1, a stem 
cell marker (Farkas and Huttner, 2008). However, only a minor increase of free MBds is 
found in the ventricular fluids (Marzesco et al., 2005). With the aid of the Tis21-GFP 
knockin mouse to more accurately distinguish proliferative (Tis21-GFP negative) 
divisions from neurogenic divisions (Tis21-GFP positive), Dubreuil et al. identified a 
significant increase in symmetric neurogenic divisions (from 0% to around 30%) starting 
after the onset of neurogenesis through mid-neurogenesis. This time line was consistent 
with data from the same group showing that the number of free MBds dramatically 
increased in the ventricular fluids as neurogenesis proceeded (Marzesco et al., 2005). So, 
it is possible that the MBds released into ventricles were derived from cells undergoing 
symmetric neurogenic divisions. This also suggests that the cells undergoing proliferative 
divisions may retain MBds (see below and Chapter 2). The Huttner‟s laboratory thus 
proposed that free MBds, as well as Prominin-1+ particles, might function as intercellular 
messengers during neurogenesis to „broadcast‟ the cells‟ identity to their neighbors and 
help balance the proliferative and neurogenic divisions of neural progenitors (Dubreuil et 
al., 2007).  
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However, we would like to provide an alternative interpretation for this 
phenomenon. Upon completion of symmetric neurogenic divisions in NE cells, the 
committed daughter cells may be programmed to actively discard MBds into ventricles, 
causing the dramatic increase in free MBds at this stage. How would this benefit 
neurogenesis? One possibility is that MBds harbor factors specifying stem cell identity, 
stem cell self-renewal, or other stem cell properties. MBd elimination in cells destined to 
differentiate could prevent their return to the fate of stem cell. In any case, additional 
studies are required to track and compare the dynamics of MBds between committed 
neurogenic cells and the NE cells throughout the neurogenesis process and to directly test 
the role of MBds in these cells. Moreover, it would be also intriguing to explore whether 
the MBd release described in culture cancerous and progenitor cells serves for 
intercellular signaling or defines cell identity/hierarchy.   
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Figure 1. A model of cytokinesis progression, abscission and fate determination of post-
abscission midbody. (a) Cytokinesis progression from early to late telophase is shown 
from top to bottom and can be generally dissected into 3 stages. Top (stage 1): Anti-
parallel microtubules (MTs) and electron-dense material initially form a patchwork at the 
midzone across the forming furrow with vesicles localizing close to the furrow. Middle 
(stage 2): As the furrow narrows, the patchwork of midzone MTs transforms into one 
major bundle between two daughter cells. The midbody is also referred to as “stem body” 
at this stage, forming at the center of the bundle. Vesicles concentrate at the ends of the 
bundle. Bottom (stage 3): As cytokinesis progresses, the connection between the two 
daughter cells extends to become the intercellular bridge and the MB core becomes a 
prominent bulge within the bridge. (b) Enlargement of inset in (a) (bottom), showing the 
process of abscission and the fate of the post-abscission midbody (MBd). Top to Middle: 
During late cytokinesis, the diameter and length of the bridge narrows and extends, 
respectively, and the density of MTs decreases. Different types of vesicles traffic to the 
MB for abscission. ESCRT is recruited to the MB and interacts with MT-severing 
proteins, presumably to function in both membrane scission and MT severing. After 
abscission, the MBd is inherited by one of the two daughter cells. Right arrow: If cells are 
differentiated or possess high autophagy (ATG) activities, MBds would be engulfed by 
autophagosomes and fused with lysosomes for degradation. Left arrow: If cells have stem 
cell-like properties or possess low ATG activities, MBd would accumulate intracellularly. 
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Figure 2. The basic organization of the midbody during late cytokinesis. 
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Figure 2. The basic organization of the midbody during late cytokinesis. (a) Electron 
micrograph of a midbody (MB) is showed in the bottom panel and an immunostained MB 
at comparable stage in the top panel. The MB can be subdivided into the MB core (center) 
and two flanking elements that connect to the intercellular bridge via the narrowed 
segments (NS). The staining of -tubulin (green) and Aurora B (red) light up the bridge 
and the flanking elements of the MB, respectively. The central dark zone (right) is 
superimposed with the region containing compact anti-parallel microtubules (MTs) and 
electron-dense material (bottom). The two daughter nuclei are stained by DAPI (right, 
blue). (b) The MB core can be further subdivided into MB matrix, which contains 
electron-dense material and anti-parallel MTs, and MB ridges, which contain dense 
material but only few MTs (arrows in the electron micrographs). Top panel is a MB 
stained for Mklp1 (red) and -tubulin (green). The Mklp1 staining is ring-like as part of 
the MB core, and presumably the MB ridges in electron micrographs are the cross-
sectioning of the MB rings visualized by immunostaining. A similar MB ring structure 
was visualized by phase-contrast microscopy (Gromley et al., 2005) and in the form of 
channels through the MB core when viewed by electron microscopy (Mullins and Biesele, 
1977). Images of immunostained MB (a, b) are provided by C.-T. Chen. Electron 
micrographs (a, b) were originally published in The Journal of Cell Biology 73(3): 672-
684. © J.M. Mullins and J.J. Biesele, 1977. Scale bars (a, b): 500 nm.   
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Chapter 2: The Asymmetric Inheritance and Post-mitotic 
Fate of Midbodies 
 
With minor alternations to standardize the format, this chapter was taken in its entirety 
from following manuscripts currently in revision: 
Midbody accumulation through evasion of autophagy contributes to cellular 
reprogramming and tumorigenicity 
Tse-Chun Kuo1, Chun-Ting Chen1, Desiree Baron, Tamer T. Onder, Sabine Loewer, 
Sandra Almeida, Cara Weismann, Ping Xu, Jean-Marie Houghton, George Q. Daley, 
Fen-Biao Gao and Stephen J. Doxsey 
The manuscript was submitted to Nature Cell Biology on July 5th 2010, revised and 
resubmitted on May 24th, 2011, and accepted on June 29th, 2011. 
1These authors contributed equally to this work 
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ABSTRACT 
The midbody (MB) is a singular organelle formed between daughter cells during 
cell division and required for their final separation in late cytokinesis. MBs can persist in 
cells long after division as midbody derivatives (MBds), but their fate is unclear. Here we 
show that MBs segregate asymmetrically to the daughter cell with the older centrosome. 
They selectively accumulate in stem cells, induced pluripotent stem (iPS) cells and 
potential cancer “stem cells” (CSCs) in vivo and in vitro. Stem cell differentiation is 
accompanied by MBd loss. MBd loss involves autophagic degradation mediated by 
binding of the autophagic receptor, NBR1, to the MB protein CEP55. These 
differentiating cells and normal dividing cells do not accumulate MBds and possess high 
autophagic activity. Stem cells and cancer cells accumulate MBds by evading 
autophagosome encapsulation and exhibit low autophagic activity. This enrichment of 
MBds is associated with enhanced reprogramming to iPS cells and increased in vitro 
tumorigenicity of cancer cells. These results suggest novel roles for MBds in stem cells 
and CSCs.  
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INTRODUCTION 
The fundamental process of cell division directs segregation of the replicated 
genome and partitioning of the cytoplasm into two daughter cells (Eggert et al., 2006). 
During division, cell fate determinants segregate asymmetrically to stem cell progenies in 
multicellular organisms (Neumüller and Knoblich, 2009). The two spindle poles 
organized by centrosomes of different ages contribute to this asymmetry (Neumüller and 
Knoblich, 2009; Doxsey et al., 2005) in that the older centrosome is inherited by the 
daughter cell that retains the stem cell fate (Yamashita et al., 2003 and 2007; Wang et al., 
2009).  
Abscission completes cell division through severing of the intercellular bridge 
between the two future daughter cells (Eggert et al., 2006; Barr and Gruneberg, 2007). 
The midbody (MB) is a large proteinaceous structure lying inside the intercellular bridge 
prior to abscission (Barr and Gruneberg, 2007; Mullins and Biesele, 1977; Gromley et al., 
2005; Steigemann et al., 2009). It was originally thought that after abscission in 
vertebrate cells (e.g. human, mouse, rat, and chicken), the post-division MB appeared to 
detach from the cell and disintegrated extracellularly, leading to the term “midbody 
remnant” (Barr and Gruneberg, 2007; Mullins and Biesele, 1977). Recent studies show 
that post-division MBs or MB derivatives (MBds) can be retained by daughter cells, 
suggesting alternative fates for these organelles (Gromley et al., 2005; Goss and Toomre, 
2008; Pohl and Jentsch, 2009).  
The fate and function of MBds is unclear. MBds in neural progenitors possess the 
putative stem cell marker CD133/prominin-1 and are thought to play a role in 
intercellular signaling in stem cells during neural development (Marzesco et al., 2005; 
Dubreuil et al., 2007). MBds can be degraded by autophagy (see below; Pohl and Jentsch, 
2009), but the relationship between MBd-accumulation and the physiological state (stem 
cell versus differentiated cell) is unknown.   
During macroautophagy (referred to as autophagy), double membrane-bound 
autophagosomes are assembled, engulf cytoplasmic constituents, and fuse with 
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lysosomes to degrade their contents (Mizushima et al., 2007 and 2008; Yorimitsu and 
Klionsky, 2007; Levine and Kroemer, 2008). Cellular homeostasis requires autophagic 
recycling of cellular components and elimination of defective ubiquitin-tagged protein 
aggregates and organelles (Mizushima et al., 2007; Yorimitsu and Klionsky, 2007; 
Levine and Kroemer, 2008; Kuma et al., 2004). During embryogenesis, autophagy 
appears to selectively clear cell fate determinants or to remodel the cell (Fimia et al., 
2007; Tsukamoto et al., 2008; Cecconi and Levine, 2008), although the cellular target(s) 
are unknown. Defects in autophagy contribute to neurodegeneration (Hara et al., 2006), 
hepatomegaly (Komatsu et al., 2005) and aging (Mizushima et al., 2008; Levine and 
Kroemer, 2008).  
Here we show that MBds accumulate in stem cells and are lost upon differentiation. 
MBd loss is mediated by the NBR1 autophagic receptor, which selectively binds the MB 
protein, CEP55. This molecular link provides a mechanism for selective degradation of 
MBds by autophagy. Evasion of autophagosome encapsulation, low autophagic activity 
and selective inheritance of MBds, together lead to MBd-accumulation in cells. Functional 
changes in reprogramming and in vitro tumorigenicity accompany manipulation of MBd 
levels suggesting non-mitotic roles for these organelles in stem cells and cancer cells.  
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RESULTS 
Post-mitotic midbodies accumulate within cells  
The cellular distribution of MBds was examined using different strategies. 
Immunofluorescence microscopy showed that multiple MBds associate with some cells, 
but the precise location was unclear (up to 20; Fig. 1a, b). Three-dimensional 
reconstruction of cells co-labeled for midbodies and the plasma membrane revealed 
intracellular localization of multiple MBds (Fig. 1d). In polarized cells, most MBds were 
positioned in the apical region at the level of the tight junctions within the cells (Fig. 1c). 
Immuno-electron microscopy confirmed the intracellular localization and revealed 
characteristic ultrastructural features of MBds (Fig. 1e; Mullins and Biesele, 1977; 
Dubreuil et al., 2007). In HeLa cells exposed to extracellular trypsin, ~70% of the cell-
associated MBds were trypsin-resistant, suggesting that they were intracellular (Fig. 1f). 
The presence of multiple intracellular MBds suggested that they could accumulate in cells 
through successive divisions.  
To more directly test for MBds outside cells, we examined 2-day co-cultures of 
HeLa cells stably expressing either monomeric RFP (cytoplasmic marker) or MKLP1-
GFP (MB marker). A fraction of MKLP1-GFP+ MBds associated with RFP+ cells (~7%; 
Fig. 1g) suggesting that MBds were released and subsequently bound to adjacent cells. 
MBds released into the medium accounted for a range of 1-10% of MBds from normal 
and cancer cells (hRPE-1, primary adult fibroblasts, dH1f, and HeLa). These 
observations resolve the conflict of previous studies suggesting, on one hand, that MBds 
are released after abscission (Mullins and Biesele, 1977) and on the other, that they are 
largely retained and degraded (Gromley et al., 2005; Pohl and Jentsch, 2009). In this 
study, MBds appeared to accumulate to very high numbers in some cells (Fig. 1a) but 
were rarely seen in others. It is this difference in MBd-accumulation that is the focus of 
this study.  
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MB
d
s are inherited by the cell with the older centrosome  
When present in multiple copies, MBds often clustered around the centrosome or 
spindle pole (data not shown and Gromley et al., 2005). This was of particular interest 
considering the reported centrosome/spindle pole-mediated segregation of MBd-sized 
proteinaceous aggresomes to one daughter cell (Johnston et al., 2002; Rujano et al., 
2006). Moreover, centrosome age-dependent differences in signaling properties have 
been observed in late cytokinesis (Anderson and Stearns, 2009). These centrosome-
associated asymmetric events prompted us to examine the relationship between 
centrosomes and MBd inheritance.  
In interphase, the G1 centrosome contains one older mother centriole (MC) and one 
younger daughter centriole (DC; Doxsey et al., 2005). After centriole duplication and 
entry into mitosis, three generations of centrioles are present: an older mother, a younger 
mother and two new daughters (Doxsey et al., 2005; Anderson and Stearns, 2009). The 
centrosome containing the older MC is termed the older centrosome (Yamashita et al., 
2007; Wang et al., 2009). In mitotic HeLa cells expressing the centriolar protein centrin1 
fused to GFP (CETN1-GFP; Piel et al., 2000), one centriole labeled more brightly than 
the other three (92.2% of cells, n=116; Fig. 2a). This centriole retained its higher intensity 
from metaphase to late cytokinesis (91.3% of cells, n=46; supplementary information, 
Fig. S1a), and exhibited extremely slow turnover rates (FRAP t1/2 ~4 hours versus 2-8 
seconds for other centrosome proteins as shown in Kallio et al., 2002, Stenoien et al., 
2003, and Leidel et al., 2003), suggesting that it was the older MC. This was confirmed 
by the more intense staining for hCenexin1 on the same older MC (Anderson and Stearns, 
2009) in both HeLa and MCF-7 cells (~90%, n=143 and n=347, respectively; Fig. 2b). 
Several other centrosome and centriole proteins showed enhanced labeling of the older 
centrosome, suggesting unambiguous differences between older and younger 
centrosomes (supplementary information, Fig. S1b).  
Using CETN1-GFP to identify the older MC; phase-contrast or DIC imaging to 
follow cell division and MB dynamics in living cells; and immunofluorescence (IF) to 
confirm MBd inheritance, we determined that MBds were preferentially inherited by the 
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cell with the older centrosome. This was observed in pluripotent human embryonic stem 
cells (hESCs; 83.3% of H9, n=18; Fig. 2d), immortalized somatic cells (91.3% of hRPE-
1, n=23) and cancer cells (U2OS: 84.6%, n=13; HeLa: 75.0%, n=24; Fig. 2c). We 
conclude that most MBds are inherited asymmetrically by the daughter cell with the older 
centrosome in several cell types.  
MB
d
s accumulate in stem cells in vivo  
Asymmetric inheritance of MBds by the daughter cell with the older centrosome 
and their abundance in subpopulations of cells suggested unique and interesting 
properties of MBd+ cells. Recent work demonstrated that the older centrosome is 
asymmetrically inherited by the stem cell during asymmetric divisions in the Drosophila 
male germ line (Yamashita et al., 2007) and the mouse neocortex (Wang et al., 2009). 
The association of the older centrosome with both MBds and stem cell divisions led us to 
ask whether MBds were found in stem cell niches of mulcticellular organisms. To test this, 
we first used MKLP1 and CEP55 antibodies to mark MBds in immunohistochemical 
preparations of human and mouse tissues.  
In seminiferous tubules of testes, stem cells and their mitotic progenies lie in the 
basal compartment. Both cell types have stem cell properties, as they can self-renew and 
replenish testes depleted of cells (Oatley and Brinster, 2008; Barroca et al., 2009). MBds 
in seminiferous tubules were confined to cells in the basal compartment, as shown by the 
discrete MKLP1 (Fig. 3a) or CEP55 (data not shown) puncta. Most cells in the basal 
compartment contained multiple MBds; eight puncta per cell could be seen in a single 
5 m section. Electron microscopy also identified multiple electron dense structures with 
MB features in individual cells (Fig. 3b, c).  
MBds in other organs were also enriched in stem cell niches. In the ventricular zone 
(VZ) of embryonic mouse brains, labeled by the stem cell marker Sox2 (Bilgüvar et al., 
2010), MBds (CD133+) were found along the ventricular side of the VZ as previously 
observed (Marzesco et al., 2005; Dubreuil et al., 2007). When cell borders were 
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demarcated by staining for the Na-K-ATPase, MBds were found associated with or within 
neural progenitors, where they accumulated (Fig. 3d). Further analysis demonstrated that 
when MBds were present in neural progenitors undergoing asymmetric divisions 
(metaphase and anaphase), the majority (75%, n=8) were within the ventricle-facing 
daughter cell and not the daughter with the committed fate (Wang et al., 2009). MBds in 
the human hair follicle were also confined to the stem cell niche, the bulge, where they 
co-labeled with the basal cell/putative stem cell marker, keratin 15 (K15; Morris et al., 
2004). MBd+ cells represented a small subset of K15+ cells, suggesting distinct 
properties of this cell population. Multiple MBds were found in this subpopulation (Fig. 
3e, f), whereas adjacent differentiating progeny were MBd-free. Finally, mouse skeletal 
muscle progenitors (SMPs) identified by -Integrin labeling (Conboy et al., 2010), had 
4-fold more MBd+ cells compared to their non-SMP counterparts, further supporting the 
presence of MBds within stem or stem-like cells. These observations suggest that MBds 
are selectively accumulated during successive divisions in vivo and retained by stem cells.  
 
MB
d
s accumulate in stem cells in vitro  
To more rigorously test the idea that MBds are selectively inherited by stem cells 
and not their differentiating progeny, we examined the fate of MBds in genetically 
matched cultured cells during transitions from pluripotency to differentiation and from 
differentiation to pluripotency. For this set of experiments, we considered MBd-
accumulation to be the percentage of cells with more than one MBd, since all cells have 
the potential to transiently retain a post-mitotic MB. A homogeneous population of 
human embryonic stem cells (H1-OGN, the Oct4-GFP knock-in H1 hESCs) was 
examined before and after differentiation into human fibroblasts (dH1f). Differentiation 
was determined by loss of embryonic stem cell markers (Oct4, Sox2, Klf4, Nanog) and 
gain of fibroblast differentiation markers (CD13; Park et al., 2008; Chan et al., 2009). 
Differentiation was accompanied by an ~8-fold reduction in MBd-accumulation (Fig. 3g, 
h). When differentiated human fibroblasts (dH1f, above) were reprogrammed to produce 
induced pluripotent stem (iPS) cells (dH1f-iPS; Zwaka and Thomson, 2003; Park et al., 
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2008), MBd-accumulation increased ~7-fold (Fig. 3h, i). Thus, MBd-accumulation can be 
manipulated in a single cell line by altering cell lineage status (e.g. pluripotency, 
differentiation) and reflects the state of MBd-accumulation in vivo.  
MB
d
-accumulation is enhanced in tumor-derived cells  
To gain further insight into cell type differences in MBd-accumulation, we 
expanded the numbers of cell lines examined and focused on differences among three 
classes of cells: stem cells, normal dividing cells and cancer cells (Fig. 4a). In general, 
primary and telomerase-immortalized normal dividing cells had very low MBd-
accumulation levels. Several hESCs and iPS cell lines showed significantly higher MBd-
accumulation levels (~7-fold on average; Fig. 4a). With one exception (see below), cells 
derived from a diversity of human cancers showed the highest level of MBd-accumulation. 
Of note, was the high level of MBd-accumulation in the breast cancer cell lines MCF-
10AT and MCF-10CA1a, compared with their non-tumorigenic parental line, MCF-10A. 
This suggests a possible relationship between MBd-accumulation and tumorigenicity. The 
common ability of stem cells and cancer cells to accumulate MBds, express stem cell 
markers (Visvader and Lindeman, 2008) and possess stem cell properties (O'Brien et al., 
2007; Pece et al., 2010) suggests a relationship between MBd-accumulation and cancer 
“initiating” or “stem” cells defined by the CSC theory (Pardal et al., 2003). 
MB
d
-accumulation does not correlate with population doubling-time or individual 
cell cycling rate  
A simple mechanism to account for the different levels of MBd-accumulation in 
different cell types is variability in proliferation rates. Slower division rates would 
provide more time for MBd-degradation, as recently proposed (Pohl and Jentsch, 2009). 
However, we observed no correlation between population doubling-time and MBd-
accumulation (Fig. 4a) as seen by comparing MCF-10A and MCF-10AT cancer cells or 
normal hRPE-1 and HeLa cancer cells (Fig. 4a).  
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It is possible that subpopulations of cells cycle at rates different from the bulk 
population. To test this, a cohort of cells was pulse-labeled with EdU (Salic and 
Mitchison, 2008). Over time, these cells showed a proportional decrease in EdU intensity, 
reflecting dilution of dye after successive divisions (Fig. 4b). The decline in EdU 
intensity with successive divisions was similar in MBd-accumulating and non-MBd-
accumulating populations in both HeLa (Fig. 4c) and SAOS cells (Fig. 4d), reflecting 
similar cell cycling rates of the two populations.  
MB
d
-accumulating cells evade membrane encapsulation of MB
d
s  
We next asked if intracellular MBd localization was different in MBd-accumulating 
(HeLa) and non-accumulating cells (hRPE-1) using the Fluorescence Protease Protection 
(FPP) assay (Lorenz et al., 2006). This method involves selective permeabilization of the 
plasma membrane followed by protease treatment, which degrades cytoplasmic structures 
but not membrane-encapsulated structures (Fig. 5a; Lorenz et al., 2006). Under these 
conditions, MKLP1-GFP+ MBds were rapidly degraded in MBd-rich HeLa cells (Fig. 5b) 
but not in MBd-poor hRPE-1 cells. Controls confirmed the integrity of membranous 
organelles (mitochondria, Golgi, peroxisomes; supplementary information, Fig. S2) and 
degradation of cytoplasmic organelles (centrioles; data not shown). We conclude that 
MBds remain free in the cytoplasm of MBd-rich cells but are sequestered within 
membrane-bound compartments of MBd-poor cells.  
Stem cells and cancer cells evade lysosomal degradation of MB
d
s  
The protease resistance of MBds and low MBd-accumulation levels in hRPE-1 cells 
(Fig. 4a and 5b) suggested that MBds were being delivered to a membranous 
compartment for degradation, such as the lysosome. In fact, MBds were often found 
within lysosomal membrane boundaries (LAMP2; Tanida et al., 2005) in MBd-poor cells 
(Fig. 5c). To follow the fate of newly formed MBds in MBd-poor cells, isolated mitotic 
cells were replated to induce roughly synchronous progression through abscission (Fig. 
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5d). If all newly formed MBds are transferred into one of the two nascent daughter cells, a 
50% maximum would be expected for MBd+ cells. Three hours after replating, MBd+ cell 
numbers peaked (~40%; Fig. 5d) followed by a peak in MBd localization to lysosomes 
(~42% at 7h). 16-19h after plating and before the next division cycle, MBd+ cells 
decreased to baseline levels (Fig. 5d). The outcome of cell synchrony and FPP assays 
showed that MBds in hRPE-1 cells enter the cytoplasm, move into lysosomes and are 
eliminated before the next cell cycle (Fig. 5b, d), suggesting lysosomal degradation of 
MBds.  
To confirm the role of lysosomes in MBd degradation, lysosomal activity was 
manipulated. Because modulation of degradation can alter MBd-accumulation status of a 
cell, total MBd levels (% MBd+ cells) were evaluated. Neutralization of acidic lysosomes 
with chloroquine or inhibition of lysosomal proteases (Tanida et al., 2005; Klinosky et al., 
2008) increased MBd+ hRPE-1 cells (up to 10-fold; Fig. 5e) and MBd localization to 
lysosomes (chloroquine: ~93.5 %; E64d/PepA: ~71.5%; Fig. 5c). However, the results 
from the FPP assay suggested that MBds might evade lysosomal degradation in MBd-rich 
cells. Indeed, lysosomal inhibition in MBd-rich cells (hESC, MCF-7) did not affect the 
percent of MBd+ cells or MBds within lysosomes (Fig. 5c, e), even in the presence of 
active lysosomal inhibitory activity (MCF-7; supplementary information, Fig. S3a). The 
modest increase in MBd+ HeLa cells (Fig. 5e), was consistent with their modest MBd-
accumulating ability (Fig. 4a). We conclude that MBd-rich cells (cancer cells, stem cells, 
see below) have a low capacity to eliminate MBds by lysosomes, so MBds are retained in 
the cytoplasm, where they accumulate. In contrast, MBd-poor cells degrade MBds in 
lysosomes, thus preventing MBd-accumulation. We next examined pathways leading to 
lysosomal degradation of cytoplasmic organelles/components.  
Autophagic degradation controls intracellular MB
d
 levels  
Reported autophagic degradation levels in MCF-7 and DLD-1 cells (Liang et al., 
1999; Sato et al., 2007) suggested a relationship between autophagy and MBd fate. The 
extremely low autophagy levels in MCF-7 cells, due to the deficiency of a crucial 
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autophagy gene, BECN1 (also known as Atg6; Liang et al., 1999), are consistent with 
high MBd-accumulation levels (~26-fold higher than differentiated cells; Fig. 4a). 
Conversely, high autophagy levels in DLD-1 cells (Sato et al., 2007) are consistent with 
low MBd-accumulation levels (~1.8-fold higher than differentiated cells; Fig. 4a). Further 
investigation showed that MBds were generally found within autophagosomes and 
lysosomes in MBd-poor cells (Fig. 5c and 6a), but rarely in MBd-rich cells even after 
lysosomal inhibition. For example, only 3.2±0.5% and 3.1±0.5% of MBds in H9 hESCs 
treated with E64d/PepA are in autophagosomes and lysosomes, respectively, compared 
with over 70% in MBd-poor hRPE-1 cells.  
To directly test whether autophagy controls MBd levels, autophagic activity was 
manipulated experimentally. Deletion of the Atg5 autophagy gene in MBd-poor MEFs 
(Kuma et al., 2004) or siRNA-mediated silencing of Atg7 in MBd-rich HeLa cells 
significantly increased MBd levels (Fig. 6b). In a reciprocal experiment, induction of 
autophagy by rapamycin and lithium chloride (Sarkar et al., 2005 and 2008) in HeLa 
cells reduced MBd levels (Fig. 6c, left). Similarly, induction of autophagy by BECN1 
(Liang et al., 1999) over-expression in MBd-rich MCF-7 cells also reduced MBd levels 
(Fig. 6c, right). These results demonstrate the crucial role of autophagy in regulating 
MBd levels in different cell types.  
If autophagy is a major regulator of MBd degradation, one would predict an inverse 
relationship between autophagic activity and MBd-accumulation. In >12 cell lines, a 
striking inverse relationship between these parameters was observed when autophagic 
flux was measured by changes in LC3-II levels (Fig. 6d, e) or p62 levels (supplementary 
information Fig. S3b;) in the presence or absence of lysosomal inhibitors (Bjorkoy et al., 
2005; Tanida et al., 2005; Mizushima and Yoshimori, 2007; Komatsu et al., 2007; 
Klinosky et al., 2008). In all cases examined, MBd-rich cells (hESCs, iPS cells; 10-20%) 
had lower autophagic activity than MBd-poor cells (MEFs, hRPE-1; ~60%). Intermediate 
autophagy levels were observed in most cancer cells except for the extremely low and 
high levels in MCF-7 (Liang et el., 1999) and DLD-1 cells (Sato et al., 2007), 
respectively. We conclude that MBd-accumulation is modulated by cell type/cell lineage-
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specific regulation of autophagic activity (Fig. 3g-i, 4, 6d and 6e) and not by division rate 
as previously suggested (Pohl and Jentsch, 2009).  
NBR1 is a novel receptor for MB
d
-specific autophagic degradation  
Autophagic degradation can be nonspecific or receptor-mediated (Mizhusima et al., 
2008). To discern between these pathways, we investigated the mammalian autophagy 
recognition molecules, p62 (Bjorkoy et al., 2005; Komatsu et al., 2007; Pankiv et al., 
2007) and NBR1 (Pankiv et al., 2007; Kirkin et al., 2009). p62 is implicated in MBd 
clearance (Pohl and Jentsch, 2009), whereas NBR1 is untested. Moreover, the molecular 
target(s) on MBds for these receptors are unknown.  
The first indication that receptor-mediated pathways were involved in cell-type-
dependent MBd degradation (Fig. 4), was the localization of NBR1 and p62 (Pohl and 
Jentsch, 2009) to mitotic MBs and MBds (Fig. 7a and data not shown). Silencing of 
NBR1 in HeLa cells increased MBd levels to Atg7-depletion levels (Fig. 6b and 7b), 
suggesting that NBR1 is likely the sole autophagic receptor for MBd degradation (Fig. 
7b). Indeed, neither deletion of the p62 gene (Komatsu et al., 2007) nor siRNA-induced 
silencing of p62 had a detectable effect on MBd levels (Fig. 7b, c) or NBR1 recruitment 
to MBds (Fig. 7a, right and data not shown).  
Immunoprecipitation for NBR1-interacting partners identified the MB protein 
CEP55. Endogenous NBR1 co-immunoprecipitated with CEP55 in hRPE-1 cells (Fig. 
7d). Over-expressed CEP55 not only increased MBd levels (Fig. 7e), but also increased 
the level of NBR1-negative MBds (Fig. 7f), presumably through NBR1 sequestration (Fig. 
7g). This indicates that CEP55 is involved in NBR1-mediated MBd degradation. This 
work identifies a unique protein pair (CEP55/NBR1) that couples MBds to the autophagic 
machinery to control MBd fate in different cell types/lineages.  
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Cells enriched in MB
d
s exhibit increased reprogramming efficiency  
We next tested the role of MBds in reprogramming (Park et al., 2008). NBR1-
specific shRNAs (shNBR1) were stably expressed in fibroblasts (dH1f) to increase MBd 
levels (~1.8-fold) over controls (shNT). NBR1-depleted cells showed increased numbers 
of tra-1-60+ iPS colonies after reprogramming by a retroviral-based cocktail (~1.6-fold; 
Fig. 8a) or a lentiviral-based cocktail (~1.9-fold). Similar results from the two different 
cocktails show that the increased efficiency of reprogramming following NBR1-
depletion-mediated increase in MBd levels is a robust phenotype. Importantly, the 
increase in iPS colonies from NBR1-depleted cells occurred without significant changes 
in autophagic activity (Fig. 8b) or population doubling-time (shNBR1: 27.3±2.5hrs; 
shNT: 26.8±4.5hrs; n=6), suggesting that this receptor is selective for degradation of 
MBds and that efficient reprogramming is not due to increased proliferation.  
Cancer cells enriched in MB
d
s exhibit increased in vitro tumorigenicity  
Because MBds selectively accumulate in stem cell niches, hESCs and iPS cells, we 
hypothesized that they may also accumulate in CSCs. MCF-7 CSCs, which have stem 
cell properties and contribute to tumor initiation (Engelmann et al., 2008), were isolated 
on the basis of Hoescht 33342 extrusion (the side population, SP; Engelmann et al., 2008). 
The SP of MCF-7 showed a 7-fold increase in MBd+ cells over the non-SP population 
(Fig. 8c).  
To more directly address the role of MBds in cancer cells, HeLa populations with 
high or low percentages of MBd+ cells, isolated by FACS on the basis of MKLP1-GFP 
signal, were tested for anchorage-independent growth. Increased colony formation was 
observed in the “MBd high” versus the “MBd low” population, and colony formation 
increased with increasing MBd levels (up to 4-fold; Fig. 8d). An increase in colony 
formation was also observed when MBds were enriched by NBR1-depletion in HeLa cells 
(Fig. 8e, left) and in mouse hepatocarcinoma cells (134-4; Fig. 8e, right). Results of all 
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three strategies suggest that MBds in cancer cell subpopulations may contribute to their 
tumorigenic potential.   
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DISCUSSION 
This work provides the first evidence for accumulation of post-mitotic MBs in stem 
cells and iPS cells in vivo and in vitro, and for their dramatic reduction in differentiated 
progeny arising from stem cells. The most important finding is that MBds appear to play a 
role in maintaining or enhancing the pluripotency of stem cells and the tumorigenicity of 
cancer cells.  
The fact that fibroblast reprogramming efficiency is increased when MBd levels are 
elevated without altering the total autophagic activity or proliferation rates of 
reprogrammed cells, suggests new roles for MBds outside cell division. In fact, 
autophagic degradation of MBds during stem cell differentiation is strikingly similar to P 
granule reduction in C. elegans embryos (Zhang et al., 2009). Like P granules, MBds are 
retained in germ or stem cells but eliminated in differentiating cells via selective 
autophagic degradation. P granules contain molecules required for cell fate specification 
(Strome et al., 2005); MBds contain stem cell markers and enhance cell fate conversion 
(present study and Marzesco et al., 2005; Dubreuil, V. et al., 2007). These common 
characteristics suggest that MBds may serve as scaffolds for organizing cell fate 
determinants.  
It is remarkable that essentially all cancer cell lines examined in this study, while 
different in origin, genomic composition, and properties, have MBd-accumulating 
subpopulations. In fact, MBd-accumulation is a common intrinsic property of both stem 
cells and cancer cells. The observation that cancer subpopulations enriched in MBds 
exhibit enhanced in vitro tumorigenicity is consistent with the CSC model characterized 
by expression of stem cell markers and potentiation of tumorigenicity (Pardal et al., 2003; 
O'Brien et al., 2007; Visvader and Lindeman, 2008; Pece et al., 2010).  
Our data identify two primary mechanisms for MBd-accumulation that utilize a 
diversity of molecular and cellular processes (Fig. 9). The first is asymmetric MBd 
inheritance (Fig. 9a). Previous studies have shown that the older centrosome is retained 
by the stem cell (Yamashita et al., 2003 and 2007; Wang et al., 2009). Asymmetric 
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delivery of the MBd to the daughter cell with the older centrosome is consistent with our 
observation that MBds accumulate in stem cells and not in their differentiated progeny. 
Thus, even though the division rate of stem cells in vivo is typically slower than other 
cells (Fuch et al., 2009), MBd-accumulation could still occur via this mechanism. Our 
results from different classes/categories of cells suggest that asymmetric MBd inheritance 
may not be specific to stem cells. It may occur in many cell types but may only be 
physiologically relevant in some, namely in stem cells and CSCs.  
Evasion of autophagic degradation is a second mechanism for MBd-accumulation 
(Fig. 9b). This is exemplified during the transition from MBd-poor differentiated cells 
with high autophagic activity to MBd-rich iPS cells with low autophagic activity, and by 
changes in MBd levels mediated by experimental manipulation of autophagy levels. MBd-
accumulation can also be mediated by uncoupling receptor-mediated entry into the 
autophagy pathway, because depletion of the NBR1 autophagic receptor or over-
expression of the corresponding ligand, CEP55, increases MBd levels. In contrast, 
another known autophagic receptor, p62, does not appear to be involved in MBd 
clearance as loss of p62 has no effect on MBd levels or the MB/MBd localization of 
NBR1 (Fig. 7a-c). Thus, autophagic degradation via NBR1 may represent a selective and 
novel pathway for autophagic elimination of MBds. In fact, although NBR1 and p62 can 
form a complex (Pankiv et al., 2007; Lamark et al., 2003), and both are required for 
efficient degradation of ubiquitinated substrates (Pankiv et al., 2007), evidence suggests 
that they may act independently as autophagic receptors (Pankiv et al., 2007). Thus, 
p62/NBR1 complex formation may not be a prerequisite for autophagic degradation. It is 
also possible that other MBd ligands exist and contribute to MBd degradation, even 
though CEP55 is the sole MB protein identified as a NBR1 binding partner thus far (Fig. 
7d). NBR1-mediated recognition of MBds could be a switch that controls MBd fate and 
may be facilitated by high autophagic activity. Regulation of these two related 
components in MBd degradation may be critical in cell fate determination.  
The proteasome system, another major cellular degradation pathway (Nedelsky et 
al., 2008) does not appear to be a major player in MBd degradation and thus, MBd fate 
determination (supplementary information, Fig. S4). However, other degradative 
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pathways could contribute to MBd degradation when autophagy is compromised, as MBd 
levels can be further increased in Atg5-/- MEFs upon lysosomal inhibition (data not 
shown). Chaperone-mediated autophagy (CMA; Mizushima et al., 2008; Majeski and 
Dice, 2004), which targets ~30% of cytosolic proteins and is upregulated upon 
compromised autophagy (Kaushik et al., 2008), might be involved in MBd degradation 
since multiple MB proteins contain CMA-targeting motifs (KFERQ-like motifs; Majeski 
and Dice, 2004).  
Other non-degradative processes may also contribute to the regulation of MBd 
levels. Elevated proliferation rate has been proposed as a factor hindering autophagic 
MBd degradation and causing MBd-accumulation in cancer and normal cells (Dubreuil et 
al., 2007). However, in this study, proliferation rate did not correlate with MBd-
accumulation across 14 cell lines, suggesting that MBd fate is instead controlled by other 
mechanisms, as described above. MBd-accumulation likely involves asymmetric 
sequestration of previously inherited MBds by the stem cell, as seen in the testes and 
neural progenitors (Fig. 3a-d). Increased MT-anchoring by the older centrosome in fly 
testes and mouse neural progenitors during asymmetric divisions could contribute to MBd 
inheritance through anchoring of MBds to the older centrosome (Yamashita et al., 2003 
and 2007; Wang et al., 2009). Release of MBds has been observed in chicken and mouse 
neural progenitors (Marzesco et al., 2005; Dubreuil et al., 2007) and in human cells (Fig. 
1g; Mullins and Biesele, 1977), and may be another, possibly minor or variable, pathway 
for eliminating MBds (or for intercellular signaling as suggested in Dubreuil et al., 2007). 
Finally, if essential for stem cell function, MBds might be distributed to both cells during 
symmetric divisions that generate two stem cells. Resolution of each of these issues 
requires further investigation.  
Collectively, our results demonstrate that MBds are more than the remnants of 
cytokinesis. Their fate is carefully and differentially controlled in different cell types and 
mediated by diverse pathways. The shared ability to accumulate MBds by stem cells and 
putative CSCs, and the striking impact on cellular phenotypes following manipulation of 
MBd levels suggest that MBds perform important cell-type specific functions that remain 
to be discovered.  
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FIGURES 
 Figure 1. MBds accumulate within cells.
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Figure 1. MB
d
s accumulate within cells. (a, b) Multiple MBds associate with a PC3 cell 
(a) and a B-lymphoblast (b). Insets (a) MBd labeling and (b) merged phase-contrast image 
with MBd labeling to show cell boundaries. MKLP1, MBd marker (a, b; red); CD44, 
membrane (a; green); DAPI, DNA (a; blue). Bar, 4 m (a) and 2µm (b). (c, d) Three-
dimensional reconstruction of polarized cells in a monolayer (c) and a HeLa cell (d) show 
intracellular MBds. (c) ZO-1, tight junction; MKLP1, MBds. Bar, 2 m. Enlargement (c, 
bottom) of box (c, top) shows five MBds (arrows). (d) Wheat germ agglutinin, plasma 
membrane (red); MKLP1-GFP, MBds (green); DAPI, DNA (blue). Bar, 5 m. (e) 
Electron micrograph of a MBd in a permeabilized MCF-7 cell showing immungold 
labeling with MKLP1 antibodies. Inset, lower magnification of the MBd (boxed) in cell; 
nucleus, right. Bar, 200nm. (f) Time-lapse images during extracellular trypsin treatment 
of HeLa cells show retention of most MBds (MKLP1-GFP, red). Two MBds (yellow 
arrows) are lost upon treatment, suggesting digestion and/or dissociation. Time (hr:min) 
post-trypsin. Bar, 5 m. (g) Two-day co-cultures of HeLa cell expressing either MKLP1-
GFP (MBd marker) or cytosolic RFP. Green MBds (arrows) associated with red cells 
(asterisk) indicate post-mitotic transfer of MBds between cells. Bar, 5µm. 
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Figure 2. MBds are preferentially inherited by the cell with the older centrosome.
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Figure 2. MB
d
s are preferentially inherited by the cell with the older centrosome. (a) 
CETN1-GFP signal is brighter in upper centrosome/spindle pole of a mitotic spindle. 
Semi-quantitative integrated intensity profile of centrioles (lower left, upper right). DIC 
image shows metaphase chromosomes (upper left). Bar, 2 m. (b) The brighter CETN1-
GFP signal represents the older centrosome as it co-stains more intensely for hCenexin1 
and remains more intense throughout cell division (supplementary information, Fig. S2). 
Bar, 4 m. Lower right, merge. (c, d) Time-lapse images showing that the mitotic MB is 
preferentially inherited by the daughter cell with the older centrosome in HeLa cells (c) 
and hESCs (d). Cells were imaged at the indicated times (hr:min) from telophase by 
phase-contrast microscopy (c) and from metaphase by DIC microscopy (d). Middle panel 
of (c) and left panel of (d), CETN1-GFP at centrosomes; enlargements and integrated 
intensity profiles show the daughter cell (c, upper; d, lower) that has the older centrosome 
and inherits the MBd (Time-lapse images: 9:59 in c; lower right image in d). Mitotic MB 
and MBds (c, d; arrows). MKLP1, MBd marker (red); -tubulin, mitotic MB and cell 
boundary marker (green); DAPI, DNA (blue). Bars, 4 m (c) and 10 m (d). 
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Figure 3. MBds accumulate in stem cells in vivo and in vitro. 
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Figure 3. MB
d
s accumulate in stem cells in vivo and in vitro. (a) Histological section 
through mouse seminiferous tubules labeled for MKLP1 shows several MKLP1+ puncta 
in cells of the basal layer where stem cells reside. Bar, 20 m. Inset, enlargement of the 
cell (arrow) (b, c) Electron micrographs of mitotic MB (b, arrow) and multiple MB-like 
structures in interphase cells with similar shape and size in a juxtanuclear position (c, 
arrows) in basal cells of mouse seminiferous tubules. N, nucleus. Bars, 1 m. (d) 
Representative planes of a neural progenitor cell in the ventricular zone (Sox2+, left-
bottom panel of d) of an E13.5 mouse brain show that an intracellular MBd (asterisk) is 
associated with the ventricle-facing daughter in the asymmetrically dividing cell (top 
row). The bottom row emphasizes the position of paired chromosomes in a dividing 
anaphase cell. CD133, MB/MBd marker (green); Na-K-ATPase, cell-border marker (red); 
DRAQ5, DNA (blue); DAPI, DNA. Ventricle (V). Bar, 5 m. Note that abscission occurs 
apically in these cells. (e) A histological section through a hair follicle (left, phase 
contrast microscopy) stains for the stem cell marker keratin 15 to identify the bulge 
region (dotted box), the stem cell niche. DNA stain (DAPI) and the phase-contrast image 
show full follicle architecture. (f) Upper panels show MBd-accumulating cells in the 
bulge region (boxed) colabelled with K15 and MKLP1. Enlargements (lower panels) of 
the boxed region highlight a cell with four MBds (asterisks). N, nucleus. Bar, 5 m. (g-i) 
Human embryonic stem cells (g, H1-OGN) induced to differentiate into CD13+ 
fibroblasts (h, dH1f) then reprogrammed to Oct4+ pluripotent stem cells (i, dH1f-iPS). 
MKLP1, MBds ; ZO-1, tight junctions; -tubulin, microtubules; Aurora B, MBs. Bar, 
10µm. 
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Figure 4. MBd-accumulation is high in stem cells and subpopulations of cancer cells and 
does not correlate with cell doubling time.  
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Figure 4. MB
d
-accumulation is high in stem cells and subpopulations of cancer cells 
and does not correlate with cell doubling time. (a) Percent of cells that accumulate 
MBds (>1) in a range of different cell types, as indicated. Below, doubling-times of 
representative cell lines aligned with MBd-accumulation data. Horizontal line, cell lines 
with different MBd-accumulation potential (14-fold) but similar doubling time. (b) Cells 
pulse-chased with EdU show a decrease in EdU intensity (x-axis) over time (y-axis), 
reflecting dilution of dye after cell divisions. Red dashed lines and bars, median and 
interquartile range, respectively. (c) After a 96hr chase period, EdU levels were 
compared in cells with different MBd numbers (y-axis). A representative graph of 
triplicate experiments is presented. Similar profiles of EdU intensities suggest similar 
division rates in HeLa cells (p=0.2101, one-way ANOVA, cells analyzed: 2008) (d) 
Representative experiment as in (c) using SAOS cells. Similarly, no significant 
differences were noted (p=0.5609, one-way ANOVA, cells analyzed: 1960).  
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Figure 5. MBds in stem and cancer cells evade membrane encapsulation and lysosomal 
degradation.  
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Figure 5. MB
d
s in stem and cancer cells evade membrane encapsulation and 
lysosomal degradation. (a) Depiction of fluorescence protease protection (FPP) assay. 
Digitonin selectively permeabilizes the plasma membrane but not internal membranes. 
Proteinase K degrades cytoplasmic components but membranous compartments remain 
intact. Under these conditions, MKLP1-GFP-tagged MBds (blue dot) in the cytoplasm 
will be degraded whereas those inside membrane compartments will not. GAPDH-dsRed 
is a cytoplasm marker that diffuses upon digitonin permeabilization. (b) MBds in MBd-
poor hRPE-1 cells are largely protected (~90% in membranous compartments, cells 
analyzed=10), whereas most MBds in HeLa cells are not (~27%, cells analyzed: 11), and 
thus degraded in cytoplasm. Bar, 5 m. (c) Graph depicting the presence of MBds in 
lysosomes upon chloroquine or E64d/pepstatin A (E64d/PepA) inhibition in hRPE-1 and 
HeLa cells, but not in MCF-7 and H9 hESCs. Chloroquine treatment of H9 hESCs is not 
included as it caused differentiation and cell death. A representative image of hRPE-1 
cells inhibited by chloroquine is shown depicting two MBds inside lysosomes. MKLP1 
and LAMP2 are used as MBd (red) and lysosome (green) markers, respectively. DAPI, 
DNA (blue). n=100 MBds/treatment. Bar, 5 m. (d) Graph showing the percent of MBd+ 
cells, the percent of MBds within lysosomes, and the percent of cells exiting cytokinesis 
following synchronization. MKLP1 and LAMP2 are used as markers as in (c). Note that 
MBds are transferred into only one of the two nascent daughter cells after abscission (Fig. 
2d), so a 50% maximum will be expected for MBd+ cells. The peak of MBds transferred 
to cells is 3h after plating followed by a peak of MBds entering lysosomes at 7h. (e) Both 
chloroquine and E64d/PepA treatments increase the percent of MBd+ cells in hRPE-1 
cells and HeLa cells (chloroquine: p=0.0021 and p=0.0187, respectively; E64d/PepA: 
p=0.0022 and p=0.0043, respectively; n=3 for all experiments). In contrast, lysosomal 
inhibition has no detectable effect on hESCs (H1, H9) and MCF-7 cancer cells. 
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Figure 6. Autophagy controls intracellular MBd levels. 
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Figure 6. Autophagy controls intracellular MB
d
 levels. (a) Single-plane confocal 
images of MBds within LC3-positive autophagosomes in MEFs expressing GFP-LC3 
(left) and in hRPE-1 cells stained for endogenous LC3 (right). MBd markers: CEP55, 
MKLP1, or mgcRACGAP. Autophagosomes: GFP-LC3 or LC3. Note that MKLP1 (blue) 
and mgcRACGAP (red) are co-localized (magenta) in the autophagosome (green), 
suggesting that MBds are sorted into autophagosomes. Bars, 2 m. (b) Decreasing 
autophagy levels by deletion of Atg5 gene (left, MEFs) or depletion of Atg7 by siRNA 
(right, HeLa) significantly increases the percent of MBd+ cells (p=0.0019 and p=0.021, 
respectively, n=3). Immunoblots confirm loss of the Atg5-Atg12 conjugation in mutant 
cells and depletion of Atg7 (arrow). (c) Rapamycin (Rapa) and lithium chloride (LiCl) 
co-treatment induces autophagy and decreases the percent of MBd+ cells (left, HeLa; 
p=0.0056, n=3). Immunoblots showing increased LC3-II levels confirm autophagy 
induction. Induction of autophagy by over-expression of Flag-tagged BECN1 reduces the 
percent of MBd+ cells (right, MCF-7; p=0.0008, n=4) (d) Representative immunoblots 
showing high autophagy levels in normal cells and low levels in stem cells and cancer 
cells. Autophagic flux was measured by changes in the levels of LC3-II, in the presence 
or absence of lysosomal inhibitors E64d/PepA. U, uninhibited. I, inhibited. Below, the 
average of the percent change in LC3-II levels after lysosomal inhibition from 3 
experiments. -tubulin, loading control. (e) Quantification of autophagic flux in different 
cell lines. Normal dividing cells (MBd-poor) typically have high autophagic flux, whereas 
stem and cancer cells (MBd-rich) have low autophagic flux. 
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Figure 7. NBR1 is a novel receptor for targeting MBds to the autophagy pathway. 
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Figure 7. NBR1 is a novel receptor for targeting MB
d
s to the autophagy pathway. (a) 
Single-plane confocal images showing co-localization of the MBd and the autophagic 
receptor, NBR1, in U2OS cells and p62 knockout MEFs. Bar, 2 m. (b) The percent of 
MBd+ cells is significantly increased following the depletion of NBR1 (p=0.022, n=3), 
but not another autophagic receptor, p62. Co-depletion of NBR1 and p62 does not further 
increase MBd+ level over NBR1 depletion alone. (c) Deletion of the p62 gene does not 
affect the percent of MBd+ cells. For (b) and (c), immunoblots verify protein loss. (d) Co-
immunoprecipitation reveals CEP55 and NBR1 form a complex. Precipitated proteins 
and 5% of the input material (Input) were analyzed by immunoblotting with antibodies 
against NBR1 or CEP55. (e-g) Overexpression of CEP55-EGFP increases the percent of 
MBd+ cells (e; p=0.0007, one-way ANOVA, n=3) and the percent of NBR1-negative 
MBds (f; p=0.0568, n=3), presumably by sequestering NBR1 (red) away from MBds in 
cells expressing CEP55-EGFP (green) as shown in (g), and consequently preventing MBd 
degradation. The dotted box in (g) is enlarged (top right panel), and the labeling of NBR1 
and CEP55-EGFP (middle and bottom right panel) are also presented. DAPI, DNA (blue). 
Bar, 10 m.  
  
82 
 
Figure 8. MBd enrichment increases reprogramming efficiency and enhances in vitro 
tumorigenicity. 
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Figure 8. MB
d
 enrichment increases reprogramming efficiency and enhances in vitro 
tumorigenicity. (a, b) Reprogramming is more efficient after MBd enrichment. 
Fibroblasts (dH1f) stably expressing NBR1-specific shRNAs (shNBR1) to enrich MBds 
show an increase in tra-1-60+ iPS colonies (a, ~1.6-fold; p=0.044) but insignificant 
changes in autophagic activity (b) over shNT control. Immunoblot (b, top) and 
densitometry (b, bottom; percent of autophagic flux) show representative result (n=3); -
tubulin, loading control. (c) MCF-7 side-population (SP) cells have a significantly higher 
percentage of MBd+ cells over the non-SP population (non-SP; p=0.0015, n=3). (d, e) 
MBd enrichment in cancer cells leads to increased anchorage-independent growth. 
MKLP1-GFP-expressing HeLa cells separated into two subpopulations, “MBd high” and 
“MBd low”. An increase in the “MBd high” over “MBd low” ratio is associated with an 
increase in soft-agar colony formation (d). No significant difference was observed when 
the enrichment of MBd high subpopulation was less than 3-fold. More soft-agar colonies 
are formed when MBds are enriched by NBR1-depletion (shNBR1) in HeLa (e, left; 
p=0.0012, n=3) and mouse 134-4 cells (e, right; p=0.0086, n=3); control, shNT. Number 
of colonies formed (d, e) is the sum of INT-violet-stained colonies from 10 random fields. 
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Figure 9. Model for MBd-accumulation in stem cells and cancer cells. 
 
  
85 
 
Figure 9. Model for MB
d
-accumulation in stem cells and cancer cells. (a) The newly 
formed MBd is preferentially inherited by the daughter cell with the older centrosome 
after asymmetric division. (b) In dividing differentiated cells, the inherited MBd (black 
ring) is recognized by the NBR1 autophagic receptor (grey circle), encapsulated by the 
autophagosome (yellow circle), and degraded after fusion of autophagosome and 
lysosome (red circle). This pathway prevents MBd-accumulation. In contrast, stem cells 
efficiently accumulate MBds through successive divisions, evasion of NBR1-mediated 
autophagy and overall lower autophagic activity.  
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SUPPLEMENTARY FIGURES 
Supplementary Figure 1. Different-aged centrosomes in dividing cells show differential 
labeling for the components and modification of centrosomes.  
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Supplementary Figure 1. Different-aged centrosomes in dividing cells show 
differential labeling for the components and modification of centrosomes. (a) 
Older/more mature centrosome retains the brighter CETN1-GFP signal throughout the 
mitotic cell cycle. Bar, 10µm. Left to right: metaphase, anaphase, telophase and 
cytokinesis. (b) The centrosome pairs in representative mitotic cells show differential 
labeling of centriolin (top and bottom panel, green) and glutamylated tubulin (bottom 
panel, red), markers for centriole maturation and for tubulin modification at centrioles, 
respectively. Centrosomes are labeled by human autoimmune antibody 5051 (top panel, 
red). DAPI stains DNA (blue). Bar, 5 m. (c) Multiple planes of confocal images 
demonstrate that the MBd (asterisk) in the ventricle-facing daughter of the dividing neural 
progenitor is intracellular (also shown in Fig. 3d). CD133, MB/MBd marker (green); Na-
K-ATPase, cell-border marker (red); DRAQ5, DNA (blue); Bar, 5 m. 
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Supplementary Figure 2. Membranous organelles are not disrupted during digitonin-
mediated permeabilization in FPP assays.  
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Supplementary Figure 2. Membranous organelles are not disrupted during 
digitonin-mediated permeabilization in FPP assays. (a) hRPE-1 cells expressing Mito-
EYFP to label mitochondria, and GAPDH-dsRed to mark cytoplasm, treated either with 
0.2% TX-100 (top panel) or with 25 M digitonin (bottom panel). TX-100 releases both 
GAPDH and Mito-EYFP from cells, whereas digitonin releases only GAPDH and does 
not disrupt mitochondrial integrity as shown by the retention of Mito-EYFP in the 
presence of Proteinase K. (b) hRPE-1 cells expressing MannII-GFP-4C, a Golgi complex 
marker (top panel), or SKL-RFP, a peroxisome marker (bottom panel), are treated with 
digitonin followed by proteinase K digestion as in (a). The fluorescent proteins in Golgi 
complex and peroxisomes are resistant to proteinase K digestion after digitonin-mediated 
permeablization, showing that the Golgi complex and peroxisomes are intact. Other 
organelles were also examined to ensure their integrity. Similar results were observed in 
HeLa cells. Bar, 5 m. 
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Supplementary Figure 3. Effects of lysosomal inhibition.  
 
Supplementary Figure 3. Effects of lysosomal inhibition. (a) DQ-BSA substrates 
fluoresce when degraded in lysosomes (left, untreated) but not when lysosomal enzymes 
are blocked (right panels) confirming function of inhibitors. Bar, 50µm. (b) Use of p62, 
another protein degraded by autophagy, as an indicator of autophagic flux confirms LC3-
II results (Fig. 6d). I, inhibited by lysosomal inhibitors as in Fig. 6d. U, uninhibited. Actin, 
loading control.  
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Supplementary Figure 4. The proteasome does not play a role in MBd degradation.  
 
 
Supplementary Figure 4. The proteasome does not play a role in MB
d
 degradation. 
(a) Ubiquitinated protein levels, assessed by anti-ubiquitin antibody, increase in cells 
treated with proteasome inhibitors (MG132, lactacystin) as indicated, confirming 
proteasome inhibition. (b) Proteasome inhibition has no significant effect on MBd 
degradation in hRPE-1 cells compared with the lysosomal inhibitor chloroquine. It only 
slightly slows the process of MBd clearance, as control cells have removed most MBds by 
19hrs. They reenter mitosis and begin to make additional MBds from 19-25 hours. Assays 
were performed by collecting mitotic cells by mitotic shake-off and treating cells with 
drugs 1h after re-plating as indicated, when most cells were in cytokinesis. This is to 
avoid arresting cells in mitosis and thus blocking MB formation. The percent of MBd+ 
cells is determined as described above. 
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MATERIALS AND METHODS 
Cell lines 
hESC lines include H1 (WA01), H9 (WA09), and Oct4-EGFP knock-in H1 (H1-OGN; 
Zwaka and Thomson, 2003). Normal differentiated lines include hRPE-1 (Clontech), 
MCF-10A, adult human fibroblasts (ATCC PCS-201-012), ex vivo C57BL/6 MEFs, and 
in vitro activated T cells. Cancer cell lines include DLD-1, HeLa, NCC-IT, PC-3, U2OS, 
SAOS-2, 134-4, MCF-7, MCF-10AT, and MCF-10CA1a, the latter two derived from 
MCF-10A. Additionally, iPS cells (dH1f-iPS) reprogrammed from the fibroblasts (dH1f) 
originally differentiated from H1-OGN cells (HSCI at Children‟s Hospital Boston; Park 
et al., 2008) were used. GFP-LC3 expressing Atg5-/-, and matched wild-type MEFs as 
well as p62-/- and matched wild-type MEFs, were grown as described (Kuma et al., 2004; 
Komatsu et al., 2005). Mouse skeletal muscle progenitor (SMP) cells were isolated as 
described (Conboy et al., 2010). Cells were grown following standard protocols and used 
within 4 (primary cultures) or 10 (established cell lines and hESCs) passages. Cells 
expressing MKLP1-GFP, monomeric RFP and CETN1-GFP were created by transfection 
or lentiviral transduction (this study and Piel et al., 2000).  
Immunofluorescence and Immunohistochemistry  
Immunofluorescence: Fixation and staining were performed as described (Gromley et al., 
2005; Marzesco et al., 2005; Xu and Davis, 2010). To label lysosomes and 
autophagosomes, cells were permeabilized with 0.05% saponin in the blocking buffer 
(10% goat serum/PBS). Images were taken on an Axiovert 2000 microscope (Zeiss) with 
PerkinElmer UltraView LAS spinning disc, or an Axioskop 2 microscope (Zeiss). Images 
were acquired, processed and analyzed with Metamorph (Molecular devices) and Imaris 
(Bitplanes Inc.).   
Immunohistochemistry: The mouse was perfused with saline followed by 4% 
paraformaldehyde/0.5% glutaraldehyde. Testes were post-fixed with 4% 
94 
 
paraformaldehyde for 2-4hrs before paraffin embedding, sectioning and immunostaining 
for MB/MBd markers (UMMS DERC Morphology Core). MB-derived rings between 
interconnected spermatocyte syncytia (Greenbaum et al., 2007) were observed if stained 
longer. Images were acquired with an Olympus BX-51 microscope.  
Electron Microscopy 
Conventional EM: The mouse was perfused with saline followed by 5% glutaraldehyde 
fixative in 50mM sodium cacodylate buffer (pH=7.4) for 30 min. Tissue was diced into 
1-mm cubes and fixation continued for 1hr at 4C. After cacodylate buffer washes, the 
cubes were stained with osmium tetroxide and uranyl acetate, embedded in Spi-
pon/Araldite, sectioned at 70-500nm before staining with 25% uranyl acetate and 
Reynold‟s lead citrate, and viewed in a Philips CM12 electron microscope with an 
Erlangshen CCD Camera (Gatan). 
Immunogold EM: MCF-7 cells on coverslips were prepermeabilized for 60sec with 
preperm buffer (80mM PIPES, pH6.8, 0.5mM EGTA, 1mM MgCl, 0.5% Triton X-100), 
fixed with 4% paraformaldehyde for 10min, labeled for MKLP1 for 1hr, processed as 
described (Mitchison et al., 1986) using 12nm gold-conjugated goat anti-rabbit IgG 
(Jackson ImmunoResearch) and embedded in Spi-pon/Araldite. 80nm sections were cut, 
stained and viewed as above.  
Time-lapse imaging  
CETN1-GFP-expressing cell lines were grown on 35mm glass-bottom culture dishes 
(MatTek dishes; MatTek Corp.) or coverslips for 2-4 days before imaging (Gromley et al., 
2005). H9 hESCs, passage 40-50, were seeded on matrigel-coated MatTek dishes, 
transduced with CETN1-GFP on the next day and grown for at least 72hrs in complete 
mTeSR1 medium (Stemcell technologies). The transduced cells were imaged every 
15min in phenol red-free D-MEM/F12 medium (Invitrogen) with mTeSR1 supplement 
and 10mM HEPES. Additional dishes with transduced cells were stained for stem cell 
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markers to ensure cell quality. After imaging, immunofluorescence was used to confirm 
MBd inheritance. 
MB
d
 quantification  
Quantification of MBd+ cells and MBd numbers was completed by immunolabeling cells 
with markers that: 1) labeled both mitotic MBs and MBds (MKLP1, mgcRACGAP, or 
CEP55); 2) labeled MBs differently than MBds ( -tubulin or Aurora B); 3) defined cell 
boundaries ( -tubulin or ZO-1). Because CEP55 also labels centrioles and 
MKLP1/mgcRACGAP also labels the spindle midzone, centrosome-specific co-staining 
(e.g. 5051 antibody) was used to identify centrosomes; a size threshold for MB and MBds 
(> 1.5 m) was also used to rule out centrosomes. MBd counts = all MB/MBd marker 
positive structures – those that had MB-specific or secondary structure labeling. Cell 
counts: For hESC lines, 5-11 colonies were imaged from triplicates in each experiment. 
For other cell types, random fields were imaged until n > 500 cells. Mitotic cells prior to 
abscission were considered one cell.   
Doubling time calculations 
Manual cell counting: 1-1.5x105 cells were seeded into 60mm culture dishes. Every 24hrs 
for four days, the total cell number from one dish was calculated in a hemocytometer. 
Timepoints vs. Log10(avg. cell counts at that timepoint) was plotted and the slope 
ascertained. T1/2 = Log10(2)/ slope.   
MTS-based colormetric proliferation assay: 2.5-5.0x103 cells were plated in triplicate in 
96-well plates. Every 24hrs, assay was performed as per manufacturer (#G3582; Promega 
Corp.) and measured by a Safire microplate reader (Tecan Group Ltd.). T1/2 was 
calculated as above substituting absorbance for cell counts. For some cell lines, both 
methods were used; similar results were obtained. 
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MB
d
 localization assays 
Extracellular trypsin treatment: MKLP1-GFP-expressing HeLa cells, plated in MatTek 
dishes and cultured for at least 48hrs, were imaged every 3 min. Their morphology 
remained similar after replacing media with PBS. Trypsin was added and the GFP+ MBds 
were monitored for the next 60-90min for signal intensity reduction (degradation) or 
movement away from cells (dissociation).   
Co-culture assay: Equal numbers of HeLa cells expressing either monomeric RFP or 
MKLP1-GFP were mixed and plated in 60mm culture dishes with coverslips. After co-
culturing for 2 days, cells were stained, and the percentage of GFP+ MBds associated 
with RFP+ cells was determined. Cell growth rates were similar (above).     
FPP assay: The FPP assay was carried out as in previous studies (Lorenz et al., 2006) 
except cells were plated in MatTek dishes 24hrs prior to co-transfection of MKLP1-GFP 
and GAPDH-dsRed (Lipofectamine 2000, Invitrogen). Cells were permeabilized then 
digested by proteinase K (50 g/ml) 5hrs after transfection. For controls, the expression 
constructs targeting mitochondria, peroxisomes, ER or Golgi were controls. 
Lysosome and proteasome assays  
Chloroquine (200 M in PBS; Sigma), E64d + pepstatin A (E64d/PepA) (10 g/ml each in 
DMSO; Sigma; Tanida et al., 2005) or solvents alone (controls) were added to 70% 
confluent cells and incubated for 22hrs before MBd counting. Lysosome inhibition was 
confirmed by incubation with 10 l/ml DQ-Red BSA (Invitrogen) for 12hrs before 
imaging. The proteasome was inhibited by 1 M MG132 (Sigma) or 50 M Lactacystin 
(Sigma) 1hr after plating mitotic hRPE-1 cells (mitotic shake-off) to allow progression 
through cytokinesis. Cells were fixed as indicated.  
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Autophagy manipulation assays 
MBds were quantified in at least 500 cells in triplicate unless otherwise noted. 
Protein depletion: siRNAs targeting human Atg7 (Yu et al., 2004), p62 (Pohl and Jentsch, 
2009), NBR1 (Kirkin et al., 2009), Lamin A/C (Gromley et al., 2005), and GFP (5‟-
NNCAUGAAGCAGCACGACUUC-3‟) were obtained (Dharmacon). Cells were 
transfected with 1 nMole siRNA (Oligofectamine, Invitrogen), and analyzed 24-48hrs 
later. MBds were quantified only in cells negative for p62 and/or NBR1 
immunofluorescence.  
Beclin1 overexpression: MCF-7 cells were either nucleofected (Amaxa) with Flag-tagged 
Beclin1 plasmid (4 g) or mock nucleofected. Flag+ cells were identified by 
immunfluorescence 48hrs later and MBds were quantified (265 Flag+ cells and 2200 
control cells; n=4 experiments). 
LiCl + rapamycin treatment: HeLa cells treated with 10mM LiCl (Sigma) and 200 nM 
rapamycin (Calbiochem), or DMSO alone were examined 24hrs later for MBd numbers.  
CEP55-GFP overexpression: Cells (1X105/well, 6-well plates) were plated 24hrs before 
CEP55-EGFP (1 g), EGFP (1 g) or mock transfection. MBd quantification and 
association with NBR1 were assessed following immunostaining 48hrs later. 
Biochemical assays 
Protease and phosphatase inhibitors, cell lysates, SDS-PAGE and immunoblotting were 
purchased or carried out as described (Gromley et al., 2005) unless specified. 
Autophagy flux determination: Lysates of E64d/PepA (I) and DMSO (U) treated cells 
were blotted with -tubulin and LC3 antibodies. LC3-II levels were determined in 
triplicate and normalized to -tubulin using Image J. Autophagic flux = |100 – ((U LC3-
II level / I LC3-II level) x 100)|.  
Immunoprecipitation: hRPE-1 cell lysates (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 
mM EDTA, 1 mM EGTA, 1% Triton X-100, 10% glycerol, 4°C) were pre-cleared for 
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1hr at 4°C (protein G-plus conjugated agarose beads, Santa Cruz) and incubated with 2 
μg normal IgG, anti-CEP55 or anti-NBR1 antibodies for 3hrs at 4°C. Protein G-plus 
conjugated agarose beads (25 μl) were added, incubated overnight at 4°C, washed in lysis 
buffer five times and exposed to SDS-PAGE and immunoblotting. 
Assays for MB
d
 functions  
Reprogramming efficiency: shRNA against NBR1 (pSM2c-shNBR1, V2MM_36901) was 
purchased and cloned into pGIPZ lentiviral vector (Open Biosystems). Fibroblasts (dH1f) 
stably expressing either NBR1-specific or non-targeting shRNA (pGIPZ-shNT) were 
puromycin-selected to establish NBR1-depleted (shNBR1) and control (shNT) lines. 
Both lines were reprogrammed by a pMIG-based 4-component cocktail, as described 
(Park et al., 2008; Chan et al., 2009). After 21 days, iPS colonies were identified by tra-
1-60 immunostaining and quantified by Image J. 
Side Population (SP) assay: MCF-7 cells were prepared, stained and incubated with or 
without FTC inhibitor (10 M; Sigma) as described (Engelmann et al., 2008). Cells were 
then resuspended in phenol red-free media with cell viability dye, 7-AAD (5 g/ml; BD 
Biosciences) and compared to unstained and 7-AAD-stained-only controls. The SP would 
be Hoechst- without inhibitor and Hoechst+ with inhibitor. 
Soft agar assays: For the FACS-based assay (above), “MBd hi” and “MBd lo” 
subpopulations of HeLa (2.5 x104/well, 6-well plates) were plated, and MBd levels in the 
“hi” and “lo” subpopulations were determined 12-15hrs after plating subpopulation 
aliquots from each sort onto coverslips. For the NBR1-silencing soft-agar assay, NBR1-
depleted (shNBR1) and control (shNT) cells (1x105 per 100-mm plate) were plated. For 
both assays, cells were plated, grown for approximately 3 weeks at 37°C, and stained, as 
described (Colburn et al., 1978; Sachdev et al., 2009). Colonies were quantified 
microscopically, and the average from triplicate wells or plates presented. 
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Antibodies  
Antibodies to the following proteins/tags were used in this study: 
Atg5 (Cosmo Bio, CAC-TMD-PH-ATG); Atg7 (ProSci, 3617); Actin (Sigma, AC-40); 
Aurora B (BD Trans Lab, 611082); CD13 (BioLegend, 301707); CD133 (eBioscience, 
14-1331); CEP55 (Abnova #H00055165-A01, #H00055165-B01 and a gift from K. 
Kurtche); hCenexin1 (a gift from K.S. Lee); Centriolin10; Flag (Sigma, F7425); GAPDH 
(Santa Cruz, SC-32233); GFP (Abcam, ab6556 and Santa Cruz, sc-9996); GT335 (a gift 
from P. Denoulet); 1-Integrin (BD Phramingen); K15 (Lab Vision, MS-1068-P); LC3 
(Nano Tools, LC3-5F10 or Novus Bio NB100-2331); LAMP2 (DSHB, H4B4); 
mgcRACGAP (Abcam, ab2270); MKLP1 (Santa Cruz, sc-867); NBR1 (Abnova, 
H00004077-B01P); p62, human samples (BD Trans Lab, 610833); p62, mouse samples 
(Progen, GP62-C); RFP (Clontech, 632496); Na-K-ATPase (DSHB, 6F); α-tubulin 
(Sigma, T9026a and Millipore, CBL270); α-tubulin-FITC (Sigma, F2168); Tra-1-60-
biotin, human samples (eBioscience, 13-8863); Ubiquitin (BD BioSci, #550944); WGA-
Alexa Fluor 555 (Molecular Probes, W32464); ZO-1-FITC (Zymed, 33-9111).  
Statistics  
Unless specified, standard deviation was shown as y error bars for bar graphs and data 
was analyzed either by Student‟s one-tailed paired t-test or unpaired with Welch‟s 
correction. When comparing multiple groups in an experiment, one-way ANOVA was 
used in conjunction with Tukey‟s test. For the EdU-labeling assay, the integrated 
intensity of labeled nuclei was first logarithmically transformed to allow the use of one-
way ANOVA. Statistically analyzed experiments were completed at least 3 times. 
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In this dissertation, colleagues in the Doxsey laboratory and I together showed 
several unexpected features around the inheritance and potential functions of post-mitotic 
midbodies, MBds. First, newly-formed MBd is inherited preferentially by the daughter 
cell possessing the older centrosome (see Chapter 2, Figure 2). Second, the majority of 
inherited MBds would be within cells (see Chapter 2, Figure 1). Third, the accumulation 
of inherited MBds is cell type-dependent (see Chapter 2, Figure 3 and 4), but not 
proliferation rate-dependent (see Chapter 2, Figure 4). Fourth, the fate of inherited MBds 
is different among cell types: MBds in immortalized somatic (differentiated) cells, but not 
in stem and cancer cells examined, appear to be directed into membrane-bound 
compartments (MBCs; see Chapter 2, Figure 5). Fifth, consistent with previous results 
(Pohl and Jentsch, 2009), the MBds in MBCs are in autophagosomal-lysosomal pathway, 
which is the main machinery for MBd clearance (see Chapter 2, Figure 5 and 6). Sixth, 
NBR1, one of the known autophagic receptors, specifically recognizes CEP55, a MB 
protein, for autophagic degradation of MBds (see Chapter 2, Figure 7). Last and most 
importantly, selective block of MBd degradation or increase MBd+ cells in the population 
with different strategies resulted in increased colony formation in soft-agar and more 
efficient reprogramming (see Chapter 2, Figure 8). In the following two sections, I would 
like to discuss our results in comparison with other published studies, and the potential 
directions that following researchers can continue to pursue.  
The correlation between centrosome age and MB
d
 inheritance 
Based on my initial experiments, the post-mitotic MBs (MBds) appeared to 
associate with one of the two daughter cells for extended time regardless how motile the 
MBd-associated cells was (data not shown). These observations led to an audacious 
hypothesis that MBd is inherited and retained by one of the two daughter cells. However, 
if both daughter cells are created equal, possessing the same ability to gain the newly-
formed MBd, I should have observed nearly half of the cells associating with MBds in any 
cultures regardless of different type of cells. That‟s not what I observed. In fact, a 
significant fraction of cells is free of MBds, and a small but steady fraction associates 
with multiple MBds (see Chapter 2, Figure 4). This implicates that the MBd inheritance 
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may be preferential towards one daughter over the other, and the mathematic modeling 
assisted by Dr. Tom Wadzinski, a former colleague in the Doxsey laboratory, further 
suggests that factor(s) eliminating pre-existing MBds (e.g. degradation intracellularly or 
shedding extracellularly) may play roles in MBd-accumulation (data not shown). Thus, 
we proposed that the asymmetric inheritance of MBds and differential activities of MBd 
degradation are the main reasons causing MBd-accumulation.  
With the expansion of analysis, I noticed that MBd-accumulation was observed 
most robustly in stem cell niches, mouse testis and developing brains, specifically (see 
Chapter 2, Figure 3 and Marzesco et al., 2005; Dubreuil et al., 2007). In line with my 
observations, studies showed that in fly testes and mouse developing neocortexes, the 
older centrosome was asymmetrically inherited in the stem cell that underwent 
asymmetric divisions (Yamashita et al., 2003 and 2007; Wang et al., 2009). These 
findings prompted me to examine if MBd inheritance correlates with centrosome age in 
dividing cultured cells. It appears to be the case (see Chapter 2, Figure 2). Of note is that 
the differences between the two centrosomes (or spindle poles) can be unambiguously 
discerned by different centrosome antigens until anaphase entry (see Chapter 2, figure 2 
and supplementary figure 1). This asymmetric MBd inheritance can be observed in 
varieties of cell types, suggesting that it is a common phenomenon accompanying the 
completion of abscission in both MBd-rich and MBd-poor cells (see Chapter 2). Therefore, 
the inefficient intracellular degradation (and/or the shedding) of MBds appears to play 
leading roles in causing MBd-accumulation, compared with the MBd inheritance.     
The first step to move forward is to examine whether centrosome age dictates this 
asymmetric MBd inheritance. As suggested in previous studies, older centrosome anchors 
more MTs than the younger one and is thus retained at the division side facing the stem 
cell niche when undergoing the asymmetric division (Yamashita et al., 2003 and 2007). 
When ninein, a well-known centrosomal and MT-anchoring protein (Mogensen et al., 
2000), is depleted in neural progenitors, the centrosome inheritance can be randomized 
during asymmetric divisions (Wang et al., 2009). A similar mechanism might also 
operate in cultured cells during abscission: different aged centrosomes possess different 
MT-anchoring abilities to gain or retain the newly-formed MBds. In this scenario, laser 
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ablation would be the best tool to test this hypothesis and presumably have least impacts 
on cellular physiology. Specifically, either or both centrosomes would be ablated during 
cytokinesis, and it is expected that the ablation of the older centrosome could randomize 
the MBd inheritance. Therefore, a pulse laser system was purchased and has been 
customized for this purpose until recently. Now, this system can reliably recapitulate the 
process of de novo centriole synthesis, and the defective MT-nucleating activity after 
centrosome ablation, as reported previously (Khodjakov et al., 2000; La Terra et al., 
2005), without causing hsp70-involved stress responses (data not shown). Preliminary 
results showed that 100% of MBds tracked were inherited by the daughter cell with the 
older centrosome when applying laser to cytoplasm (n=4) or ablating the younger 
centrosome (n=3) during cytokinesis. In contrast, only 66% of the MBds tracked after 
laser ablation of the older centrosome in the daughter cell show the same trend of 
inheritance. No detectable change in cytokinesis progression was observed in laser-
treated cells. Since it is too early to make any solid conclusion with limited numbers of 
cells and MBds imaged, I plan to repeat experiments more times and in more cell lines.     
As reviewed in Chapter 1 and can be envisioned, the asymmetric MBd inheritance is 
less likely to result from synchronous fusion- or ESCRT-mediated abscission, which may 
release the newly-formed MBd from both daughter cells. Thus, asymmetric or sequential 
bridge cutting by ESCRT-mediated membrane scission or by vesicle delivery/fusion 
could be better candidates for such inheritance. Recent studies showed that ESCRT-III 
components were recruited to both sides of the midbody but constrict the bridge in a 
sequential fashion (Guizetti et al., 2011; Elia et al., 2011). Conceptually similar is the 
observed asymmetric buckled MT-severing events, presumably allowing vesicle fusion to 
extend and narrow the bridge caliber for the following bridge cutting (Schiel et al., 2011). 
If laser ablation on older centrosomes does randomize MBd inheritance, it would be 
interesting to explore the centrosome age-dependent MBd inheritance in the context of the 
asymmetric MT-severing as well as the sequential ESCRT-mediated scission. In other 
words, the randomized MBd inheritance may be due to the reversed or randomized 
manner of MT-severing and ESCRT-mediated constriction. This would potentially 
provide insights for how different-aged centrosomes would dictate MBd inheritance.  
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Alternative pathways for MB
d
 internalization and degradation 
As shown in Chapter 2, a significant fraction of inherited MBds are found within 
cells and within MBCs of MBd-low cells (Figure 1 and 5). These MBCs were later shown 
to be autophagosomes and lysosomes (Figure 5 and 6). Thus, we and the Jentsch group 
envisioned that asymmetric abscission causes the newly-formed MBd residing within 
cytoplasm and then directed to autophagic machinery.  
However, more recent study from the Rubinsztein laboratory showed that the 
endocytosed plasma membrane could also directly contribute to the formation of pre-
autophagosomal structures (Ravikumar et al., 2010). This finding has broad implications, 
one of which is that the endocytosed membrane (and/or cargos) may not necessarily go 
all the way down to endosomal and lysosomal pathways, but may connect to autophagic 
machinery. Specifically, a „disconnected‟ membrane-wrapped MBd may be endocytosed 
and then directed to autophagosome via the interaction between clathrin and Atg16L, a 
molecule crucial for autophagosome biogenesis (Ravikumar et al., 2010). Therefore, 
asymmetric abscission may no longer be the reason why MBds are subjective to 
autophagic degradation. Given that the sequential bridge cutting was reported recently 
(Guizetti et al., 2011; Elia et al., 2011; Schiel et al., 2011), it becomes important to know 
whether these „disconnected‟ MBds (after sequential bridge cutting) are phagocytosed. If 
so, further investigations are surely required to know whether these phagocytosed MBds 
are delivered to lysosomes directly, transferred to autophagosomes, or kept in cytoplasm. 
As shown in Chapter 2, a system was developed to show that MBds can be transferred 
between different cells. The same system can also be employed to study whether the 
transferred (disconnected) MBds will be phagocytosed. These questions would also 
provide new insights into how excess MBds might be acquired and managed to serve their 
non-mitotic functions (see Chapter 2, Figure 8). Moreover, it might provide new tools to 
manipulate MBd numbers in cells („MBd transplantation‟) to more rigorously examine the 
non-mitotic roles of MBd, as shown and proposed in our current model (see Chapter 2, 
Figure 9).  
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